Advanced Flower Capital Inc. 10-K

Item 9A. Controls and Procedures Evaluation of Disclosure Controls and Procedures The Company maintains disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in the Company’s reports under the Exchange Act is recorded, processed, and summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. An evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Annual Report was made under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures (a) are effective to ensure that information required to be disclosed by us in reports filed or submitted under the Exchange Act is timely recorded, processed, summarized and reported and (b) include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Management’s Annual Report on Internal Control over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a‐15(f) and 15d-15(f) of the Exchange Act. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures are being made only in accordance with authorizations of management and our directors; and (iii) provide reasonable assurance regarding prevention or timely detection of the unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Management has assessed the effectiveness of our internal control over financial reporting as of December 31, 2024, using the framework specified in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on such assessment, management has concluded that our internal control over financial reporting was effective as of December 31, 2024. This Annual Report does not include an attestation report of our independent registered public accounting firm regarding control over financial reporting. Management’s report was not subject to attestation by our independent registered public accounting firm pursuant to Section 989G of the Dodd-Frank Wall Street and Consumer Protection Act, which exempts non-accelerated filers from the auditor attestation requirement of Section 404(b) of the Sarbanes-Oxley Act. 97 Table of Contents Effectiveness of Internal Control It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system will be met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events. Because of these and other inherent limitations of control systems, there is only the reasonable assurance that our controls will succeed in achieving their goals under all potential future conditions. Changes in Internal Control over Financial Reporting There have been no changes to our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended December 31, 2024, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Item 9B. Other Information Insider Trading Arrangements None of the Company’s directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the Company’s fiscal quarter ended December 31, 2024. Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections Not applicable. PART III Item 10. Directors, Executive Officers and Corporate Governance Except as set forth below, the other information required by this item will be contained in the Company’s definitive proxy statement for its 2025 Annual Shareholder Meeting, to be filed with the SEC within 120 days after December 31, 2024, and is incorporated herein by reference. Code of Business Conduct and Ethics We have adopted a Code of Business Conduct and Ethics for our directors, officers (including our principal executive officer, principal financial officer and principal accounting officer) and employees. A current copy of the code is posted under “Corporate Governance” on our website at https://investors.advancedflowercapital.com/corporate-governance/governance-overview . To the extent required by rules adopted by the Securities and Exchange Commission and Nasdaq, we intend to promptly disclose future amendments to certain provisions of the Code of Business Conduct and Ethics, or waivers of such provisions granted to executive officers and directors on our website at https://investors.advancedflowercapital.com/corporate-governance/governance-overview/ . Item 11. Executive Compensation The information required by this item is incorporated by reference to the Company’s definitive proxy statement for its 2025 Annual Shareholder Meeting, to be filed with the SEC within 120 days after December 31, 2024 and is incorporated herein by reference. Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters The information required by this item is incorporated by reference to the Company’s definitive proxy statement for its 2025 Annual Shareholder Meeting, to be filed with the SEC within 120 days after December 31, 2024 and is incorporated herein by reference. 98 Table of Contents Item 13. Certain Relationships and Related Party Transactions, and Director Independence The information required by this item is incorporated by reference to the Company’s definitive proxy statement for its 2025 Annual Shareholder Meeting, to be filed with the SEC within 120 days after December 31, 2024 and is incorporated herein by reference. Item 14. Principal Accountant Fees and Services The information required by this item is incorporated by reference to the Company’s definitive proxy statement for its 2025 Annual Shareholder Meeting, to be filed with the SEC within 120 days after December 31, 2024 and is incorporated herein by reference. PART IV Item 15. Exhibits and Financial Statement Schedules (1) Financial Statements—See the Index to Consolidated Financial Statements, together with the report thereon of CohnReznick LLP dated March 13, 2025, beginning on Page F-1. (2) Financial Statement Schedules—None. We have omitted financial statement schedules because they are not required or are not applicable, or the required information is shown in the consolidated financial statements or notes to the consolidated financial statements. (3) Exhibits. Exhibit No. Description of Exhibits 2 .1 Separation and Distribution Agreement, dated as of July 8, 2024, by and between Advanced Flower Capital Inc. (formerly known as AFC Gamma, Inc.) and Sunrise Realty Trust, Inc. (filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K on July 8, 2024 and incorporated herein by reference). 3.1 Articles of Amendment and Restatement of Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.) (filed as Exhibit 3.2 to the Company’s Registration Statement on Form S-11 on January 22, 2021 and incorporated herein by reference). 3.1A Articles of Amendment, dated March 10, 2022 (filed as Exhibit 3.1A to the Company’s Annual Report on Form 10-K on March 10, 2022 and incorporated herein by reference). 3 .1B Articles of Amendment, dated October 22, 2024 (filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K on October 22, 2024 and incorporated herein by reference). 3.4 Amended and Restated Bylaws of Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.) (filed as Exhibit 3.4 to the Company’s Registration Statement on Form S-11 on January 22, 2021 and incorporated herein by reference). 3.4A Second Amended and Restated Bylaws of Advanced Flower Capital Inc., dated October 22, 2024 (filed as Exhibit 3.2 to the Company’s Current Report on Form 8-K on October 22, 2024 and incorporated herein by reference). 4.1 Description of Capital Stock (filed as Exhibit 4.1 to the Company’s Annual Report on Form 10-K on March 10, 2022 and incorporated herein by reference). 4.2 Indenture, dated as of November 3, 2021, by and between Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.) and TMI Trust Company, as trustee (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K on November 3, 2021 and incorporated herein by reference). 4.3 Form of 5.750% Senior Notes due 2027 (included in Exhibit 4.2). 10.1 Amended and Restated Management Agreement, dated January 14, 2021 by and between Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.) and AFC Management, LLC (filed as Exhibit 10.1 to the Company's Annual Report on Form 10-K on March 10, 2022 and incorporated herein by reference). 10.1A First Amendment to Amended and Restated Management Agreement, dated March 10, 2022, by and between Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.) and AFC Management, LLC (filed as Exhibit 10.1A to the Company’s Annual Report on Form 10-K on March 10, 2022 and incorporated herein by reference). 99 Table of Contents 10.1B Second Amendment to Amended and Restated Management Agreement, dated November 7, 2022, by and between Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.) and AFC Management, LLC (filed as Exhibit 10.1B to the Company’s Quarterly Report on Form 10-Q on November 8, 2022 and incorporated herein by reference). 10.1C Third Amendment to Amended and Restated Management Agreement, dated March 6, 2023 by and between Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.) and AFC Management, LLC (filed as Exhibit 10.1C to the Company’s Annual Report on Form 10-K on March 7, 2023 and incorporated herein by reference). 10.1D Fourth Amendment to Amended and Restated Management Agreement, dated September 11, 2023 by and between Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.) and AFC Management, LLC (filed as Exhibit 10.1D to the Company’s Current Report on Form 8-K on September 12, 2023 and incorporated herein by reference). 10.1E Fifth Amendment to Amended and Restated Management Agreement, dated February 22, 2024 by and between Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.) and AFC Management, LLC (filed as Exhibit 10.1E to the Company’s Current Report on Form 8-K on February 22, 2024 and incorporated herein by reference). 10.2 Tax Matters Agreement, dated as of July 8, 2024, by and between Advanced Flower Capital Inc. (formerly known as AFC Gamma, Inc.) and Sunrise Realty Trust, Inc. (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K on July 8, 2024 and incorporated herein by reference). 10.3 Form of Indemnification Agreement between the Registrant and each of its directors and officers (filed as Exhibit 10.2 to the Company’s Registration Statement on Form S-11 on January 22, 2021 and incorporated herein by reference). 10.4 Form of Indemnification Agreement between Registrant and each of the Investment Committee members (filed as Exhibit 10.3 to the Company’s Registration Statement on Form S-11 on January 22, 2021 and incorporated herein by reference). 10.5 Form of Registration Rights Agreement, by and among Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.) and the holders thereto (filed as Exhibit 10.4 to the Company’s Registration Statement on Form S-11 on December 28, 2020 and incorporated herein by reference). 10.6§ 2020 Stock Incentive Plan (filed as Exhibit 10.5 to the Company’s Registration Statement on Form S-11 on January 22, 2021 and incorporated herein by reference). 10.7 Secured Revolving Credit Agreement, dated August 18, 2020, by and among Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.), as borrower, AFC Finance, LLC, as agent, and AFC Finance, LLC and Gamma Lending Holdco LLC, as lenders (filed as Exhibit 10.6 to the Company’s Registration Statement on Form S-11 on December 28, 2020 and incorporated herein by reference). 10.7A Amendment to Revolving Credit Agreement, dated as of May 7, 2021, by and among Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.), as borrower, AFC Finance, LLC, as agent, and AFC Finance, LLC and Gamma Lending Holdco LLC, as lenders (filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q on May 11, 2021 and incorporated herein by reference). 10.7B Second Amendment to Revolving Credit Agreement, dated as of November 3, 2021, by and among Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.), as borrower, and AFC Finance, LLC, as and lender (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K on November 3, 2021 and incorporated herein by reference). 10.8 Unsecured Revolving Credit Agreement, dated December 17, 2024, by and among Advanced Flower Capital Inc., as borrower, the lenders party thereto from time to time, and AFC Finance, LLC, as agent and lender (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K on December 17, 2024 and incorporated herein by reference). 10.9† Loan and Security Agreement, dated April 29, 2022, by and among Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.), as Borrower, and the lenders that are party thereto (filed as Exhibit 10.7 to the Company’s Current Report on Form 8-K on May 2, 2022 and incorporated herein by reference). 10. 9 A † Amendment Number One to Loan and Security Agreement, dated March 26, 2024, by and among AFC Gamma, Inc., as Borrower, and the lenders that are party thereto (filed as Exhibit 10.7A to the Company’s Current Report on Form 8-K on March 29, 2024 and incorporated herein by reference). 10.9 B † Amendment Number Two to Loan and Security Agreement, dated July 18, 2024, by and among Advanced Flower Capital Inc. (formerly known as AFC Gamma, Inc.), as Borrower, and the lenders that are party thereto (filed as Exhibit 10.7B to the Company’s Quarterly Report on Form 10-Q on August 7, 2024 and incorporated herein by reference). 100 Table of Contents 10.9 C* † Amendment Number Three to Loan and Security Agreement, dated January 24, 2025, by and among Advanced Flower Capital Inc. (f/k/a AFC Gamma, Inc.), as Borrower, and the lenders that are party thereto. 10.10§ Employment Agreement, dated January 3, 2023, by and between AFC Management, LLC and Brandon Hetzel (filed as Exhibit 10.8 to the Company’s Annual Report on Form 10-K on March 7, 2024 and incorporated herein by reference). 10.11§ Employment Agreement, dated October 30, 2023, by and between AFC Management, LLC and Daniel Neville (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K on October 30, 2023 and incorporated herein by reference). 1 9* Insider Trading Policy. 21.1* List of Subsidiaries of the Registrant. 23.1* Consent of CohnReznick LLP, independent registered public accounting firm. 31.1* Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2* Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1** Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2** Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 97 Clawback Policy (filed as Exhibit 97 to the Company’s Annual Report on Form 10-K on March 7, 2024 and incorporated herein by reference). 101.INS Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. 101.SCH Inline XBRL Taxonomy Extension Schema Document. 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document. 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document. 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document. 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) § Management contract or compensatory plan or arrangement * Filed herewith ** Furnished herewith † The registrant has omitted portions of the referenced exhibit pursuant to Item 601(b) of Regulation S-K because such portions are both (i) not material and (ii) the type of information that the registrant customarily and actually treats as private and confidential. Item 16. Form 10-K Summary None. 101 Table of Contents INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Report of Independent Registered Public Accounting Firm CohnReznick LLP (PCAOB ID 596 ), Baltimore, Maryland F- 2 Consolidated Balance Sheets as of December 31, 202 4 and 202 3 F- 3 Consolidated Statements of Operations for the years ended December 31, 202 4 and 202 3 F- 4 Consolidated Statements of Shareholders’ Equity for the years ended December 31, 202 4 and 202 3 F- 5 Consolidated Statements of Cash Flows for the years ended December 31, 202 4 and 202 3 F- 6 Notes to Consolidated Financial Statements F- 8 F-1 Table of Contents REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Board of Directors and Shareholders Advanced Flower Capital Inc. Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Advanced Flower Capital Inc. and subsidiary as of December 31, 2024 and 2023, and the related consolidated statements of operations, shareholders’ equity, and cash flows for the years then ended, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of Advanced Flower Capital Inc. and subsidiary as of December 31, 2024 and 2023, and the results of their operations and their cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America. Basis for Opinion These consolidated financial statements are the responsibility of the entity’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to Advanced Flower Capital Inc. in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Advanced Flower Capital Inc. is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. Emphasis of Matter As further described in Note 10, Advanced Flower Capital Inc. is subject to significant risks and uncertainties due to originating, structuring, underwriting and managing senior secured loans and other types of loans for established cannabis industry operators. /s/ CohnReznick LLP We have served as Advanced Flower Capital Inc.’s auditor since 2020. Baltimore, Maryland March 13, 2025 F-2 Table of Contents ADVANCED FLOWER CAPITAL INC. CONSOLIDATED BALANCE SHEETS As of December 31, 2024 2023 Assets Loans held for investment at fair value (cost of $ 50,241,018 and $ 71,644,003 at December 31, 2024 and 2023, respectively, net) $ 30,510,804 $ 61,720,705 Loans held for investment at carrying value, net 293,262,374 301,265,398 Loan receivable held at carrying value, net 1,895,638 2,040,058 Current expected credit loss reserve ( 30,419,677 ) ( 26,309,450 ) Loans held for investment at carrying value and loan receivable held at carrying value, net of current expected credit loss reserve 264,738,335 276,996,006 Cash and cash equivalents 103,610,460 90,381,831 Accounts receivable — 1,837,450 Interest receivable 1,982,897 3,715,995 Prepaid expenses and other assets 1,214,817 688,446 Assets of discontinued operations — 31,244,622 Total assets $ 402,057,313 $ 466,585,055 Liabilities Accrued interest $ 894,611 $ 894,000 Due to affiliate 6,754 16,437 Dividends payable 7,369,866 9,819,695 Current expected credit loss reserve 166,702 115,473 Accrued management and incentive fees 1,932,246 3,471,726 Accrued direct administrative expenses 1,197,518 1,486,256 Accounts payable and other liabilities 501,328 704,685 Senior notes payable, net 88,612,150 88,014,558 Line of credit payable 60,000,000 42,000,000 Line of credit payable to affiliate 40,000,000 — Liabilities of discontinued operations — 10,000 Total liabilities 200,681,175 146,532,830 Commitments and contingencies (Note 10) Shareholders’ equity Preferred stock, par value $ 0.01 per share, 10,000 shares authorized at December 31, 2024 and 2023 and 0 and 125 shares issued and outstanding at December 31, 2024 and 2023, respectively — 1 Common stock, par value $ 0.01 per share, 50,000,000 shares authorized at December 31, 2024 and 2023 and 22,332,927 and 20,457,697 shares issued and outstanding at December 31, 2024 and 2023, respectively 223,329 204,577 Additional paid-in capital 251,865,763 349,805,890 Accumulated (deficit) earnings ( 50,712,954 ) ( 29,958,243 ) Total shareholders’ equity 201,376,138 320,052,225 Total liabilities and shareholders’ equity $ 402,057,313 $ 466,585,055 See accompanying notes to the consolidated financial statements F-3 Table of Contents ADVANCED FLOWER CAPITAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS Years ended December 31, 2024 2023 Revenue Interest income $ 51,991,789 $ 70,290,345 Interest expense ( 6,336,308 ) ( 6,357,457 ) Net interest income 45,655,481 63,932,888 Expenses Management and incentive fees, net (less rebate of $ 947,969 and $ 1,693,133 , respectively) 10,361,821 14,064,305 General and administrative expenses 3,967,764 5,005,134 Stock-based compensation 1,390,978 1,008,148 Professional fees 1,563,484 1,478,410 Total expenses 17,284,047 21,555,997 (Provision for) reversal of current expected credit losses ( 4,161,456 ) ( 12,132,718 ) Realized gains (losses) on investments, net ( 93,338 ) ( 1,340,476 ) Gain (loss) on extinguishment of debt — 1,986,381 Change in unrealized gains (losses) on loans at fair value, net ( 9,806,916 ) ( 8,513,364 ) Net income from continuing operations before income taxes 14,309,724 22,376,714 Income tax expense 447,587 1,659,337 Net income from continuing operations 13,862,137 20,717,377 Net income from discontinued operations, net of tax 2,922,068 234,622 Net income $ 16,784,205 $ 20,951,999 Basic earnings per common share: Continuing operations $ 0.64 $ 1.01 Discontinued operations $ 0.14 $ 0.01 Total basic earnings per common share $ 0.78 $ 1.02 Diluted earnings per common share: Continuing operations $ 0.64 $ 1.01 Discontinued operations $ 0.14 $ 0.01 Total diluted earnings per common share $ 0.78 $ 1.02 Weighted average number of common shares outstanding: Basic weighted average shares of common stock outstanding 20,821,239 20,321,091 Diluted weighted average shares of common stock outstanding 20,888,980 20,345,919 See accompanying notes to the consolidated financial statements F-4 Table of Contents ADVANCED FLOWER CAPITAL INC. CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY Year Ended December 31, 2024 Preferred Stock Common Stock Additional Paid-In- Capital Accumulated Earnings (Deficit) Total Shareholders’ Equity Shares Amount Balance at December 31, 2023 $ 1 20,457,697 $ 204,577 $ 349,805,890 $ ( 29,958,243 ) $ 320,052,225 Issuance of common stock, net of offering costs — 1,582,960 15,829 15,561,994 — 15,577,823 Stock-based compensation — 292,270 2,923 1,388,055 — 1,390,978 Dividends declared on common shares ($ 1.77 per share) — — — — ( 37,531,416 ) ( 37,531,416 ) Dividends declared on preferred shares ($ 60 per share) — — — — ( 7,500 ) ( 7,500 ) Redemption of preferred shares ( 1 ) — — ( 124,999 ) — ( 125,000 ) Distributions in connection with the Spin-Off — — — ( 114,765,177 ) — ( 114,765,177 ) Net income — — — — 16,784,205 16,784,205 Balance at December 31, 2024 $ — 22,332,927 $ 223,329 $ 251,865,763 $ ( 50,712,954 ) $ 201,376,138 Year Ended December 31, 2023 Preferred Stock Common Stock Additional Paid-In- Capital Accumulated Earnings (Deficit) Total Shareholders’ Equity Shares Amount Balance at December 31, 2022 $ 1 20,364,000 $ 203,640 $ 348,817,914 $ ( 9,962,186 ) $ 339,059,369 Stock-based compensation — 93,697 937 987,976 — 988,913 Dividends declared on common shares ($ 2.00 per share) — — — — ( 40,933,056 ) ( 40,933,056 ) Dividends declared on preferred shares ($ 120 per share) — — — — ( 15,000 ) ( 15,000 ) Net income — — — — 20,951,999 20,951,999 Balance at December 31, 2023 $ 1 20,457,697 $ 204,577 $ 349,805,890 $ ( 29,958,243 ) $ 320,052,225 See accompanying notes to the consolidated financial statements F-5 Table of Contents ADVANCED FLOWER CAPITAL INC. CONSOLIDATED STATEMENTS OF CASH FLOWS Years ended December 31, 2024 2023 Operating activities: Net income $ 16,784,205 $ 20,951,999 Net income from discontinued operations, net of tax ( 2,922,068 ) ( 234,622 ) Net income from continuing operations 13,862,137 20,717,377 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Provision for (reversal of) current expected credit losses 4,161,456 12,132,718 Realized (gains) losses on investments, net 93,338 1,340,476 (Gain) loss on extinguishment of debt — ( 1,986,381 ) Change in unrealized (gains) losses on loans at fair value, net 9,806,916 8,513,364 Accretion of deferred loan original issue discount and other discounts ( 7,969,729 ) ( 6,143,832 ) Amortization of deferred financing costs - revolving credit facility 392,551 309,213 Amortization of deferred financing costs - senior notes 632,592 641,662 Stock-based compensation 1,390,978 988,913 Payment-in-kind interest ( 3,141,777 ) ( 10,931,732 ) Changes in operating assets and liabilities: Accounts receivable — ( 38,687 ) Interest receivable 1,733,098 1,542,717 Prepaid expenses and other assets ( 634,683 ) ( 346,815 ) Interest reserve — ( 4,700,944 ) Accrued interest 611 ( 142,667 ) Accrued management and incentive fees, net ( 1,539,480 ) ( 420,008 ) Accrued direct administrative expenses ( 288,738 ) ( 357,396 ) Accounts payable and other liabilities ( 213,040 ) ( 133,666 ) Net cash provided by (used in) operating activities of continuing operations 18,286,230 20,984,312 Net cash provided by (used in) operating activities of discontinued operations 3,271,445 244,622 Net cash provided by (used in) operating activities 21,557,675 21,228,934 Cash flows from investing activities: Issuance of and fundings on loans ( 112,486,938 ) ( 51,757,225 ) Proceeds from sales of loans 96,061,029 21,312,827 Principal repayment of loans 58,788,329 58,963,777 Net cash provided by (used in) investing activities of continuing operations 42,362,420 28,519,379 Net cash (used in) provided by investing activities of discontinued operations ( 47,211,339 ) — Net cash provided by (used in) investing activities ( 4,848,919 ) 28,519,379 Cash flows from financing activities: Proceeds from sale of common stock 15,848,060 — Payment of offering costs - equity offering ( 270,237 ) — Payment of financing costs ( 275,612 ) ( 225,000 ) Redemption of preferred shares ( 125,000 ) — Cash distribution in connection with the Spin-Off of SUNS ( 67,913,215 ) — Borrowings on revolving credit facilities 285,000,000 63,000,000 Repayment of revolving credit facility ( 227,000,000 ) ( 81,000,000 ) Dividends paid to common and preferred shareholders ( 39,988,745 ) ( 42,532,201 ) Repayment of senior notes — ( 7,737,500 ) Net cash (used in) provided by financing activities of continuing operations ( 34,724,749 ) ( 68,494,701 ) Net cash provided by (used in) financing activities of discontinued operations — — Net cash provided by (used in) financing activities ( 34,724,749 ) ( 68,494,701 ) Net increase (decrease) in cash and cash equivalents ( 18,015,993 ) ( 18,746,388 ) Cash and cash equivalents, beginning of period 121,626,453 140,372,841 Cash and cash equivalents, end of period $ 103,610,460 $ 121,626,453 F-6 Table of Contents Supplemental disclosure of non-cash activity: Interest reserve withheld from funding of loans $ — $ 1,500,000 OID withheld from funding of loans $ 6,231,309 $ 7,398,475 Dividends declared and not yet paid $ 7,369,866 $ 9,819,695 Non-cash funding of new loan $ 14,672,640 $ — Non-cash net assets distribution in connection with the spin-off of SUNS $ 46,851,962 $ — Supplemental information: Interest paid during the period $ 5,310,554 $ 5,549,250 Income taxes paid during the period $ 1,267,500 $ 1,655,821 See accompanying notes to the consolidated financial statements F-7 Table of Contents ADVANCED FLOWER CAPITAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS As of December 31, 2024 1. ORGANIZATION Advanced Flower Capital Inc. (formerly known as AFC Gamma, Inc.) (the “Company” or “AFC”) is an institutional lender that was founded in July 2020 by a veteran team of investment profe ssionals. The Company primarily originates, structures, underwrites, invests in and manages senior secured mortgage loans and other types of loans and debt securities, with a specialization in loans to cannabis industry operators in states that have legalized medical and/or adult-use cannabis. The Company is a Maryland corporation and completed its initial public offering (the “IPO”) in March 2021. The Company is externally managed by AFC Management, LLC, a Delaware limited liability company (the Company’s “Manager”), pursuant to the terms of the Amended and Restated Management Agreement, dated January 14, 2021, between the parties (as amended from time to time, the “Management Agreement”). The Company’s wholly-owned subsidiary, AFCG TRS1, LLC, a Delaware limited liability company (“TRS1”), operates as a taxable real estate investment trust subsidiary (a “TRS”). TRS1 began operating in July 2021, and the financial statements of TRS1 are consolidated within the Company’s consolidated financial statements. On July 9, 2024, the Company completed the spin-off (the “Spin-Off”) of the Company’s wholly-owned subsidiary, Sunrise Realty Trust, Inc. (“SUNS”), which held the Company’s commercial real estate (“CRE”) loan portfolio, into an independent, publicly traded REIT, SUNS. In connection with the Spin-Off, the operating results of the SUNS business through the date of the Spin-Off are reported in net income from discontinued operations, net of tax in the consolidated statements of operations for all periods presented. The related assets and liabilities are reported as assets and liabilities of discontinued operations on the consolidated balance sheets. Cash flows from the Company’s discontinued operations are presented as such in the consolidated statements of cash flows for all periods presented. Unless otherwise noted, all amounts and disclosures included in the notes to consolidated financial statements reflect only the Company’s continuing operations. For additional information, see Note 17, “Discontinued Operations.” The Company operates in one operating segment. The Company is solely focused on senior secured loans to cannabis industry operators in states where medical and/or adult-use cannabis is legal. These loans are generally held for investment and are typically secured, directly or indirectly, by real estate, equipment, cash flows and the value associated with licenses (where applicable) and/or other assets of borrowers depending on the applicable laws and regulations governing such borrowers. The Company has elected to be taxed as a real estate investment trust (“REIT”) for United States federal income tax purposes under the Internal Revenue Code of 1986, as amended (the “Code”). The Company generally will not be subject to United States federal income taxes on its REIT taxable income as long as it annually distributes all of its REIT taxable income prior to the deduction for dividends paid to shareholders and complies with various other requirements as a REIT. 2. SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements and related notes have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company, and its wholly-owned subsidiary. The consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary for the fair presentation of the Company’s results of operations and financial condition as of and for the periods presented. All intercompany balances and transactions have been eliminated in consolidation. Cash and Cash Equivalents Cash and cash equivalents include funds on deposit with financial institutions, including demand deposits with financial institutions. Cash and short-term investments with an original maturity of three months or less when acquired are considered cash and cash equivalents for the purpose of the consolidated balance sheets and consolidated statements of cash flows. F-8 Table of Contents Concentration of Credit Risks Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, loans and interest receivable. The Company places its cash and cash equivalents with financial institutions, and, at times, cash held exceeds the Federal Deposit Insurance Corporation insured limit. The Company and the Manager seek to manage this credit risk by monitoring the financial institutions and their ability to continue in business for the foreseeable future. The Company has exposure to credit risk on its loans and interest receivable. The Company and the Manager seek to manage credit risk by performing due diligence prior to origination or acquisition and through the use of non-recourse financing, when and where available and appropriate. Investments in Loans The Company originates commercial real estate (“CRE”) debt and related instruments generally to be held for investment. The Company accretes or amortizes any discounts or premiums on loans held for investment over the life of the related loan held for investment utilizing the effective interest method. Loans are generally collateralized by real estate, equipment, cash flows and the value associated with licenses (where applicable) and/or other assets of borrowers. The extent of any credit deterioration associated with the performance and/or value of the underlying collateral property and the financial and operating capability of the borrower could impact the expected amounts received. The Company monitors performance of its portfolio of loans held for investment under the following methodology: (1) borrower review, which analyzes the borrower’s ability to execute on its original business plan, reviews its financial condition, assesses pending litigation and considers its general level of responsiveness and cooperation; (2) economic review, which considers underlying collateral (i.e., leasing performance, unit sales and cash flow of the collateral and its ability to cover debt service, as well as the residual loan balance at maturity); (3) property review, which considers current environmental risks, changes in insurance costs or coverage, current site visibility, capital expenditures and market perception; and (4) market review, which analyzes the collateral from a supply and demand perspective of similar property types, as well as from a capital markets perspective. Loans are generally placed on nonaccrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the loan is placed on nonaccrual status. Interest payments received on nonaccrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding the borrower’s ability to make pending principal and interest payments. Nonaccrual loans are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current. The Company may make exceptions to placing a loan on nonaccrual status if the loan has sufficient collateral value and is in the process of collection. The Company may make modifications to loans, including loans that are in default. Loan terms that may be modified include interest rates, required prepayments, maturity dates, covenants, principal amounts and other loan terms. The terms and conditions of each modification vary based on individual circumstances and will be determined on a case-by-case basis. The Manager monitors and evaluates each of the Company’s loans held for investment and has maintained regular communications with borrowers. Loans Held at Fair Value Investments in loans at fair value are carried at fair value in the Company’s consolidated balance sheets, with changes in fair value recorded through earnings. Refer to Note 14 for more information on the valuations of the investments. Although the Company generally holds its target loans as long-term investments, the Company may occasionally classify some of its loans as held for sale. Loans held for sale are carried at fair value, with changes in fair value recorded through earnings. Loan transactions are recorded on the trade date at cost, net of any original issue discounts. Realized gains or losses are measured by the difference between the net proceeds from the repayment or sale and the amortized and/or accreted cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include loans charged off during the period, net of recoveries. F-9 Table of Contents An unrealized gain arises when the value of the loan portfolio exceeds its cost and an unrealized loss arises when the value of the loan portfolio is less than its cost. The change in unrealized gains or losses primarily reflect the change in loan values, including the reversal of previously recorded unrealized gains or losses when gains or losses are realized. Loans Held at Carrying Value Investments in loans held at carrying value are carried at cost, net of unamortized loan original issue discount and origination costs and other original issue discounts (the “carrying value”) in the Company’s consolidated balance sheets. The Company follows Accounting Standards Codification (“ASC”) 842 for certain loans which are considered financial assets not eligible to elect the fair value option due to the structure of the loans. These loans are carried at cost, net of unamortized loan original issue discount and origination costs and other original issue discounts (the “carrying value”) in the Company’s consolidated balance sheets. Fair Value Measurements The Company follows ASC 825-10, Recognition and Measurement of Financial Assets and Financial Liabilities (“ASC 825-10”), which provides companies the option to report selected financial assets and liabilities at fair value. ASC 825-10 also establishes presentation and disclosure requirements designed to facilitate comparisons between companies that choose different measurement attributes for similar types of assets and liabilities and to more easily understand the effect of the company’s choice to use fair value on its earnings. ASC 825-10 also requires entities to display the fair value of the selected assets and liabilities on the face of the balance sheet. The Company has elected the ASC 825-10 option to report selected financial assets and liabilities at fair value. The Company also follows ASC 820-10, Fair Value Measurements Overall (“ASC 820-10”), which defines fair value, establishes a framework for measuring fair value in accordance with GAAP and expands disclosure of fair value measurements. ASC 820-10 determines fair value to be the price that would be received for an investment in a current sale, which assumes an orderly transaction between market participants on the measurement date. ASC 820-10 requires the Company to assume that the transaction is sold in its principal market to market participants or, in the absence of a principal market, the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact. In accordance with ASC 820-10, the Company has considered its principal market as the market in which the Company exits its loans with the greatest volume and level of activity. ASC 820-10 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. In accordance with ASC 820-10, these inputs are summarized in the three broad levels listed below: • Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. • Level 2—Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly. • Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. If inputs used to measure fair value fall into different levels of the fair value hierarchy, a loan’s level is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the loan. This includes loans that are valued using “bid” and “ask” prices obtained from independent third-party pricing services or directly from brokers. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, the Company obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company’s loans for which quotations are available. In determining the fair value of a particular loan, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. GAAP requires disclosure of fair value information about financial and nonfinancial assets and liabilities, whether or not recognized in the financial statements, for which it is practical to estimate the value. In cases where quoted market prices are not available, fair values are based upon the application of discount rates to estimated future cash flows using market yields, or other valuation methodologies. Any changes to the valuation methodology will be reviewed by the Company’s F-10 Table of Contents management to ensure the changes are appropriate. The methods used may produce a fair value calculation that is not indicative of net realizable value or reflective of future fair values. Furthermore, while the Company anticipates that the valuation methods are appropriate and consistent with other market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial and nonfinancial assets and liabilities could result in a different estimate of fair value at the reporting date. The Company uses inputs that are current as of the measurement date, which may fall within periods of market dislocation, during which price transparency may be reduced. Current Expected Credit Losses The Company measures current expected credit losses (“CECL”) in accordance with Accounting Standards Codification (“ASC”) Topic 326, Financial Instruments - Credit Losses (Topic 326), which requires a methodology that reflects on both the outstanding balances and unfunded commitments on loans held for investment and requires consideration of a broader range of historical experience adjusted for current conditions and reasonable and supportable forecast information to derive credit loss estimates (the “CECL Reserve”). Subsequent period increases and decreases to expected credit losses impact earnings and are recorded within the provision for current expected credit losses in the Company’s consolidated statements of operations. The CECL Reserve related to outstanding balances on loans held for investment required under Topic 326 is a valuation account that is deducted from the amortized cost basis of the Company’s loans held at carrying value and loan receivable held at carrying value in the Company’s consolidated balance sheets. The CECL Reserve related to unfunded commitments on loans held at carrying value is recorded within the current expected credit loss reserve financial statement line in the Company’s consolidated balance sheets. The Company has elected not to measure an allowance for credit losses for accrued interest receivable. The Company estimates CECL Reserve using a model that considers multiple datapoints and methodologies that may include the likelihood of default and expected loss given default for each individual loan, discounted cash flows (“DCF”), and other inputs which may include the risk rating of the loan, how recently the loan was originated compared to the measurement date, and expected prepayment if applicable. Calculation of the CECL Reserve requires loan specific data, which may include fixed charge coverage ratio, loan-to-value, property type and geographic location. Estimating the CECL Reserve also requires significant judgment with respect to various factors, including but not limited to (i) the appropriate historical loan loss reference data, (ii) the expected timing of loan repayments, (iii) calibration of the likelihood of default to reflect the risk characteristics of the Company’s loan portfolio and (iv) the Company’s current and future view of the macroeconomic environment. The Company may consider loan-specific qualitative factors on certain loans to estimate its CECL Reserve, which may include (i) whether cash from the borrower’s operations is sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and (iii) the liquidation value of collateral. For loans where the Company has deemed the borrower/sponsor to be experiencing financial difficulty, the Company may elect to apply a practical expedient in which the fair value of the underlying collateral is compared to the amortized cost of the loan in determining a specific CECL allowance. See Note 6 included in these consolidated financial statements for CECL related disclosures. Stock-Based Compensation The Company accounts for stock-based compensation issued to employees and the Board of Directors pursuant to the Amended and Restated Stock Incentive Plan (the “2020 Plan”) under the fair value method. This method measures compensation cost at the date of grant based on the value of the award and recognizes the cost over the service period, which is usually the vesting period. The fair value of equity-based compensation awards is based on the estimated fair value of the Company’s common stock, as determined by management using a valuation model and approved by the Board of Directors. Fair values of award grants also recognize any ongoing restrictions on the sale of securities. Debt Issuance Costs Debt issuance costs related to the Company’s indebtedness are capitalized and amortized over the term of the respective debt instrument utilizing the effective interest method. Unamortized debt issuance costs are expensed when the associated debt is repaid prior to maturity. Amortization of debt issuance costs is included within interest expense in the Company’s consolidated statements of operations. The unamortized balance for the senior notes is recorded within senior notes payable in these consolidated financial statements. The unamortized balance for the revolving credit facility is recorded as within prepaid expenses and other assets on these consolidated financial statements. See Note 9 included in these consolidated financial statements for further consideration. F-11 Table of Contents Payment-in-Kind Interest The Company has loans in its portfolio that contain payment-in-kind (“PIK”) provisions. The PIK interest computed at the contractual rate specified in each applicable agreement is accrued and added to the principal balance of the loan monthly in arrears and recorded as interest income. The PIK income added to the principal balance is generally collected upon repayment of the outstanding principal. To maintain the Company’s status as a REIT, this non-cash source of income is included in taxable income and will increase the dividend paid to shareholders for the year earned, even though the Company has not yet collected the cash. Revenue Recognition Interest income from loans is accrued based on the outstanding principal amount and the contractual terms of each loan. Origination fees, direct loan origination costs, and other discounts (in aggregate the “Original Issue Discount” or “OID”) are also recognized in interest income from loans over the initial loan term as a yield adjustment using the effective interest method. Management places loans on nonaccrual status when principal or interest payments are past due 30 days or more or when full recovery of interest and principal is doubtful. Accrued and unpaid interest is generally reversed against interest income in the period the loan is placed on nonaccrual status. Interest payments received on nonaccrual loans are generally recognized on a cash basis and may be recognized as income or applied to principal depending upon management’s judgment regarding the borrower’s ability to make pending principal and interest payments. Nonaccrual loans are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current. The Company may make exceptions to placing a loan on nonaccrual status if the loan has sufficient collateral value and is in the process of collection. Delayed draw loans earn interest or unused fees on the undrawn portion of the loan, which is recognized as interest income in the period earned. Other fees, including prepayment fees and exit fees, are recognized as interest income when received. Interest reserves The Company utilizes interest reserves on certain loans to fund the interest payments. Such reserves are established at the time of loan origination. The interest reserve represents a deposit received from the borrower for future loan interest payments. It is recorded as a liability as it represents unearned interest revenue. The interest reserve is relieved when the interest on the loan is earned and interest income is recorded in the period when the interest is earned in accordance with the credit agreement. The interest payment is deducted from the interest reserve deposit balance when the interest payment is due. The decision to establish a loan-funded interest reserve is made during the underwriting process and considers the feasibility of the project, the creditworthiness and expertise of the borrower, and the debt coverage provided by the real estate and other pledged collateral. It is the Company’s policy to recognize income for this interest component as long as the borrower is progressing as originally projected and if there has been no deterioration in the financial standing of the borrower or the underlying project. The Company’s standard policies for interest income recognition are applied to all loans, including those with interest reserves. Income Taxes The Company is a Maryland corporation and has elected to be taxed as a REIT under the Code, commencing with its taxable year ended December 31, 2020. The Company believes that its proposed method of operation will enable it to qualify as a REIT. However, no assurances can be given that the Company’s beliefs or expectations will be fulfilled, since qualification as a REIT depends on the Company satisfying numerous asset, income and distribution tests which depend, in part, on the Company’s operating results. To qualify as a REIT, the Company must meet a number of organizational and operational requirements. Those qualification tests involve the percentage of income that the Company earns from specified sources, the percentage of the Company’s assets that fall within specified categories, the diversity of the ownership of the Company’s shares, and the percentage of the Company’s taxable income that the Company distributes. The Company is required to distribute annually to its shareholders at least 90% of the Company’s REIT taxable income prior to the deduction for dividends paid. To the extent that the Company distributes less than 100% of its REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), the Company will pay tax at regular corporate rates on that undistributed portion. Furthermore, the Company will be subject to a 4% nondeductible excise tax on any amount by which distributions the Company pays with respect to any calendar year (including any F-12 Table of Contents distributions declared by the last day of the calendar year but paid in the subsequent year) are less than the sum of (1) 85% of our ordinary income, (2) 95% of our capital gain net income and (3) 100% of our undistributed income from prior years. The annual expense is calculated in accordance with applicable tax regulations. Excise tax expense is included in the financial statement line item income tax expense. The Company’s wholly-owned subsidiary, TRS1, operates as a TRS and began operating in July 2021. A TRS is an entity taxed as a corporation that has not elected to be taxed as a REIT, in which a REIT directly or indirectly holds equity, and that has made a joint election with such REIT to be treated as a TRS. A TRS generally may engage in any business, including investing in assets and engaging in activities that could not be held or conducted directly by the Company without jeopardizing its qualification as a REIT. A TRS is subject to applicable United States federal, state and local income tax on its taxable income. In addition, as a REIT, the Company also may be subject to a 100% excise tax on certain transactions between it and its TRS that are not conducted on an arm’s-length basis. The income tax provision is included in the line item income tax expense, including excise tax. The Company accounts for income taxes related to any TRS under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the income statement in the period that includes the enactment date. FASB ASC Topic 740, Income Taxes (“ASC 740”), prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company has analyzed its various federal and state filing positions and believes that its income tax filing positions and deductions are well documented and supported as of December 31, 2024. Based on the Company’s evaluation, there is no reserve for any uncertain income tax positions. Accrued interest and penalties, if any, are included within other liabilities in the consolidated balance sheets. The Company files income tax returns in the United States federal jurisdiction as well as various state and local jurisdictions. The filings are subject to normal reviews by tax authorities until the related statute of limitations expires. As of December 31, 2024 , tax years since 2020 remain subject to examination by taxing authorities. Earnings per Share The Company calculates basic earnings (loss) per share by dividing net income (loss) allocable to common shareholders for the period by the weighted average shares of common stock outstanding for that period after consideration of the earnings (loss) allocated to the Company’s restricted stock, which are participating securities as defined in GAAP. Diluted earnings (loss) per share takes into effect any dilutive instruments, such as stock options, restricted stock, restricted stock units (“RSUs”) and convertible debt, except when doing so would be anti-dilutive. As of December 31, 2024, there were dilutive instruments relating to stock options and restricted shares. See Note 12 included in these consolidated financial statements for the earnings per share calculations. Use of Estimates in the Preparation of Financial Statements The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of loans held for investment at fair value and current expected credit losses. Recently Adopted Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023 - 07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, early adoption is permitted. The amendments should be applied retrospectively to all prior period s presented in the financial statements. Upon transition, the segment expense categories and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in the period of adoption. The Company has adopted ASU 2023-07 effective December 31, 2024 and concluded that the application of this guidance did not have any material impact on its consolidated financial statements. See Note 18 for more information on the effects of the adoption of ASU 2023-07. F-13 Table of Contents Recent Accounting Pronouncements Pending Adoption In December 2023, the FASB issued ASU 2023-09—Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 improves the transparency of income tax disclosures related to rate reconciliation and income taxes. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. For entities other than public business entities, the amendments are effective for annual periods beginning after December 15, 2025. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The amendments should be applied prospectively, however, retrospective application is permitted. The adoption of ASU 2023-09 is not expected to have a material impact on the Company’s consolidated financial statements. In November 2024, the FASB issued ASU 2024-03—Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”) and in January 2025, the FASB issued ASU 2025-01—Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date (“ASU 2025-01”), which requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. ASU 2024-03, as clarified by ASU 2025-01, is effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The adoption of ASU 2024-03 is not expected to have a material impact on the Company’s consolidated financial statements. 3. LOANS HELD FOR INVESTMENT AT FAIR VALUE As of December 31, 2024 and 2023, the Company’s portfolio included one and two loans held at fair value, respectively. The aggregate commitment under these loans was approximately $ 44.4 million and $ 94.2 million, respectively, and outstanding principal was approximately $ 53.1 million and $ 71.9 million as of December 31, 2024 and 2023, respectively. For the year ended December 31, 2024, the Company funded approximately $ 4.6 million in new loans and additional principal and received approximately $ 5.2 million of principal repayments of loans held at fair value and sold $ 19.3 million of the Company’s investment in Private Company B. As of December 31, 2024 and 2023, none of the Company’s loans held at fair value had floating interest rates. The following tables summarize the Company’s loans held at fair value as of December 31, 2024 and 2023: As of December 31, 2024 Fair Value (1) Carrying Value (2) Outstanding Principal (2) Weighted Average Remaining Life (Years) (3) Senior term loan $ 30,510,804 $ 50,241,018 $ 53,108,449 0.0 Total loan held at fair value $ 30,510,804 $ 50,241,018 $ 53,108,449 0.0 As of December 31, 2023 Fair Value (1) Carrying Value (2) Outstanding Principal (2) Weighted Average Remaining Life (Years) (4) Senior term loans $ 61,720,705 $ 71,644,003 $ 71,883,402 0.4 Total loans held at fair value $ 61,720,705 $ 71,644,003 $ 71,883,402 0.4 (1) Refer to Note 14. (2) The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount (“OID”) and loan origination costs. (3) As of December 31, 2024, the maturity date passed on the credit facility with Private Company A without repayment. F-14 Table of Contents (4) Weighted average remaining life is calculated based on the fair value of the loans as of December 31, 2023. As of December 31, 2023, the weighted average remaining life only reflects the remaining life of the Private Company A Credit Facility. The following table presents changes in loans held at fair value as of and for the year ended December 31, 2024: Principal Original Issue Discount Unrealized Gains (Losses) Fair Value Total loans held at fair value at December 31, 2023 $ 71,883,402 $ ( 239,399 ) $ ( 9,923,298 ) $ 61,720,705 Change in unrealized gains (losses) on loans at fair value, net — — ( 9,806,916 ) ( 9,806,916 ) New fundings 4,594,027 ( 2,756,416 ) — 1,837,611 Accretion of original issue discount — 128,384 — 128,384 Loan repayments ( 5,218,919 ) — — ( 5,218,919 ) Sale of loans ( 19,284,846 ) — — ( 19,284,846 ) PIK interest 1,134,785 — — 1,134,785 Total loans held at fair value at December 31, 2024 $ 53,108,449 $ ( 2,867,431 ) $ ( 19,730,214 ) $ 30,510,804 The following table presents changes in loans held at fair value as of and for the year ended December 31, 2023: Principal Original Issue Discount Unrealized Gains (Losses) Fair Value Total loans held at fair value at December 31, 2022 $ 102,376,546 $ ( 1,740,561 ) $ ( 1,409,934 ) $ 99,226,051 Realized gains (losses) on loans at fair value, net ( 1,213,416 ) — — ( 1,213,416 ) Change in unrealized gains (losses) on loans at fair value, net — — ( 8,513,364 ) ( 8,513,364 ) New fundings 1,881,840 — — 1,881,840 Accretion of original issue discount — 1,501,162 — 1,501,162 Loan repayments ( 34,900,946 ) — — ( 34,900,946 ) PIK interest 3,739,378 — — 3,739,378 Total loans held at fair value at December 31, 2023 $ 71,883,402 $ ( 239,399 ) $ ( 9,923,298 ) $ 61,720,705 As of December 31, 2024 , the Company ha d one l oan held at fair value on nonaccrual status. Effective March 1, 2024, the Company placed Private Company A on nonaccrual status with an outstanding principal amount of approximately $ 53.1 million and an unrealized loss of approximately $( 19.7 ) million as of December 31, 2024 . During the year ended December 31, 2023, the credit facility with Public Company A matured without repayment. The agent on the credit facility has placed the borrower in default, and the Company recorded a realized loss of approximately $( 1.2 ) million for the year ended December 31, 2023 . A more detailed listing of the Company’s loan held at fair value portfolio based on information available as of December 31, 2024 is as follows: Collateral Location Collateral Type (1) Fair Value (2) Carrying Value (3) Outstanding Principal (3) Interest Rate Maturity Date (4) Payment Terms (5) Private Co. A AZ, GA, MA, NM C, D $ 30,510,804 $ 50,241,018 $ 53,108,449 15.5 % (6) 5/8/2024 I/O Total loan held at fair value $ 30,510,804 $ 50,241,018 $ 53,108,449 (1) C = Cultivation Facilities, D = Dispensary/Retail Facilities. (2) Refer to Note 14. F-15 Table of Contents (3) The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of OID and loan origination costs. (4) Certain loans are subject to contractual extension options and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications. (5) I/O = interest-only, P/I = principal and interest. P/I loans may include interest-only periods for a portion of the loan term. (6) Base weighted average interest rate of 13.0 % and payment-in-kind (“PIK”) weighted average interest rate of 2.5 %. In October 2023, AFC Agent LLC (“AFC Agent”) delivered a notice of default to Private Company A based on certain financial and other covenant defaults and began charging additional default interest of 5.0 %, beginning as of July 1, 2023, in accordance with the terms of the Private Company A Credit Facility. Effective March 1, 2024, the Company placed the borrower on nonaccrual status. The maturity date passed on the credit facility to Private Company A without repayment. In November 2023, Private Company A was placed into receivership to maintain the borrower’s operations and maximize value for the benefit of its creditors. The court-appointed receiver is determining the amount of principal payments the borrower is able to repay either from operations or from sale of collateral assets on a monthly basis. 4. LOANS HELD FOR INVESTMENT AT CARRYING VALUE As of December 31, 2024 and 2023, t he Company’s portfolio included fourteen and nine loans held at carrying value, respectively. A s of December 31, 2024 and 2023, t he aggregate originated commitment under these loans was approximately $ 312.8 million and $ 333.1 million, resp ectively, and outstanding principal was approximately $ 301.8 million and $ 314.4 million, respectively. During the year ended December 31, 2024, the Company funded approximately $ 128.8 million of new loans and additional principal, had approximately $ 53.4 million of principal repayments of loans held at carrying value and sold $ 90.0 million in the aggregate of the Company’s investments in Subsidiary of Public Company H and Subsidiary of Public Company M. As of December 31, 2024 and 2023, approximately 52 % and 84 %, respectively, of the Company’s loans held at carrying value had floating interest rates. As of December 31, 2024, t hese floating benchmark rates included one-month Secured Overnight Financing Rate (“SOFR”) subject to a weighted average floor of 3.8 % and quoted at 4.3 %. The following tables summarize the Company’s loans held at carrying value as of December 31, 2024 and 2023: As of December 31, 2024 Outstanding Principal (1) Original Issue Discount Carrying Value (1) Weighted Average Remaining Life (Years) (2) Senior term loans $ 301,755,791 $ ( 8,493,417 ) $ 293,262,374 1.9 Total loans held at carrying value $ 301,755,791 $ ( 8,493,417 ) $ 293,262,374 1.9 As of December 31, 2023 Outstanding Principal (1) Original Issue Discount Carrying Value (1) Weighted Average Remaining Life (Years) (2) Senior term loans $ 314,376,929 $ ( 13,111,531 ) $ 301,265,398 2.2 Total loans held at carrying value $ 314,376,929 $ ( 13,111,531 ) $ 301,265,398 2.2 (1) The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted OID and loan origination costs. (2) Weighted average remaining life is calculated based on the carrying value of the loans as of December 31, 2024 and 2023. F-16 Table of Contents The following table presents changes in loans held at carrying value as of and for the year ended December 31, 2024: Principal Original Issue Discount Carrying Value Total loans held at carrying value at December 31, 2023 $ 314,376,929 $ ( 13,111,531 ) $ 301,265,398 New fundings 128,796,860 ( 3,474,893 ) 125,321,967 Accretion of original issue discount — 7,841,345 7,841,345 Loan repayments ( 46,126,637 ) — ( 46,126,637 ) Sale of loans ( 90,000,000 ) 251,662 ( 89,748,338 ) PIK interest 2,006,992 — 2,006,992 Loan amortization payments ( 7,298,353 ) — ( 7,298,353 ) Total loans held at carrying value at December 31, 2024 $ 301,755,791 $ ( 8,493,417 ) $ 293,262,374 The following table presents changes in loans held at carrying value as of and for the year ended December 31, 2023: Principal Original Issue Discount Carrying Value Total loans held at carrying value at December 31, 2022 $ 296,584,529 $ ( 11,407,417 ) $ 285,177,112 New fundings 59,088,860 ( 7,713,475 ) 51,375,385 Accretion of original issue discount — 4,642,670 4,642,670 Loan repayments ( 18,600,105 ) — ( 18,600,105 ) Sale of loans ( 24,606,578 ) 1,366,691 ( 23,239,887 ) PIK interest 7,192,354 — 7,192,354 Loan amortization payments ( 5,282,131 ) — ( 5,282,131 ) Total loans held at carrying value at December 31, 2023 $ 314,376,929 $ ( 13,111,531 ) $ 301,265,398 As of December 31, 2024 and 2023 , the Company had two and three loans held at carrying value on nonaccrual status, respectively. During the year ended December 31, 2024, the Company successfully exited its loan with Private Company I, which was previously placed on nonaccrual status, effective May 1, 2023. The Company was repaid on all remaining principal and past interest due upon exiting the loan. The Company placed Subsidiary of Private Company G on nonaccrual status effective December 1, 2023, with an outstanding principal amount of approximately $ 79.2 million and an amortized cost of approximately $ 77.8 million as of December 31, 2024 . Subsidiary of Private Company G was previously placed on nonaccrual status during various periods in 2023. The Company will recognize income related to loan activity only upon receipt of cash. During the year ended December 31, 2024, the Company recognized interest income of approximately $ 6.9 million related to this loan, which was received in cash. The Company placed Private Company K on nonaccrual status effective December 1, 2023, with an outstanding principal amount of approximately $ 12.2 million and an amortized cost of approximately $ 11.5 million as of December 31, 2024 . The Company will recognize income related to loan activity only upon receipt of cash. During the year ended December 31, 2024, the Company received a $ 1.3 million payment applied to the outstanding principal balance and recognized interest income of approximately $ 0.5 million related to this loan received in cash. F-17 Table of Contents A more detailed listing of the Company’s loans held at carrying value portfolio based on information available as of December 31, 2024 is as follows: Collateral Location Collateral Type (1) Outstanding Principal (2) Original Issue Discount Carrying Value (2) Interest Rate Maturity Date (3) Payment Terms (4) Sub. of Private Co. G NJ, PA C, D $ 79,215,888 $ ( 1,444,847 ) $ 77,771,041 12.5 % (5) 5/1/2026 I/O Private Co. K MA C, D 12,195,762 ( 682,619 ) 11,513,143 18.3 % (6) 5/3/2027 P/I Private Co. J MO C, D 24,290,184 ( 131,197 ) 24,158,987 18.3 % (7) 9/1/2025 P/I Private Co. L OH C, D 34,129,999 ( 587,300 ) 33,542,699 13.0 % (8) 5/1/2026 P/I Sub. of Public Co. M IL, MA, MD, MI, NJ, OH, PA C, D 2,797,527 ( 138,061 ) 2,659,466 9.5 % (9) 8/27/2025 I/O Private Co. M AZ D 29,599,498 ( 2,527,251 ) 27,072,247 9.0 % (10) 7/31/2026 P/I Private Co. N - Real Estate FL C, D 19,327,505 ( 634,046 ) 18,693,459 12.5 % (11) 4/1/2028 P/I Private Co. N - Non-Real Estate FL C, D 17,200,000 ( 559,000 ) 16,641,000 12.5 % (12) 4/1/2028 P/I Private Co. O AZ, MD, MO, NJ, NV, NY, OH, OR, Canada C 3,347,647 ( 256,250 ) 3,091,397 13.5 % (13) 6/1/2028 P/I Private Co. P MI C, D 15,609,914 ( 376,000 ) 15,233,914 13.0 % (14) 7/1/2027 P/I Private Co. Q GA C, D 5,817,755 ( 403,333 ) 5,414,422 13.8 % (15) 9/1/2028 P/I Private Co. R MD C, D 39,519,968 ( 753,513 ) 38,766,455 12.0 % (16) 11/1/2027 P/I Sub. of Public Co. S FL, IL, MA, NY, OH, PA C, D 10,000,000 — 10,000,000 9.5 % (17) 8/12/2026 I/O Private Co. T UT C, D 8,704,144 — 8,704,144 11.3 % (18) 7/26/2027 P/I Total loans held at carrying value $ 301,755,791 $ ( 8,493,417 ) $ 293,262,374 (1) For cannabis operators, C = Cultivation Facilities, D = Dispensary/Retail Facilities. (2) The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted OID and loan origination costs. (3) Certain loans are subject to contractual extension options and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications. (4) I/O = interest-only, P/I = principal and interest. P/I loans may include interest-only periods for a portion of the loan term. (5) Base interest rate of 12.5 %. Effective March 2024, pursuant to the 2024 Subsidiary of Private Company G Forbearance Agreement, Subsidiary of Private Company G transitioned from a floating interest rate tied to U.S. prime rate to a fixed interest rate. Effective December 1, 2023, the Company placed the borrower on nonaccrual status. (6) Base interest rate of 12.0 % plus SOFR (SOFR floor of 1.0 %) and PIK interest rate of 2.0 %. As amended by the forbearance agreement entered into in March 2024, between 20.0 % and 80.0 % of the monthly cash interest was paid in kind from December 1, 2023 to June 1, 2024. Effective December 1, 2023, the Company placed the borrower on nonaccrual status. (7) Base interest rate of 12.0 % plus SOFR (SOFR floor of 1.0 %) and PIK interest rate of 2.0 %. (8) Base interest rate of 8.0 % plus SOFR (SOFR floor of 5.0 %). (9) Base interest rate of 9.5 %. (10) Base interest rate of 9.0 %. Quarterly cash interest was paid in kind from closing to February 1, 2024 and then payable in cash thereafter. (11) Base interest rate of 8.0 % plus SOFR (SOFR floor of 4.5 %). (12) Base interest rate of 8.0 % plus SOFR (SOFR floor of 4.5 %). (13) Base interest rate of 8.5 % plus SOFR (SOFR floor of 5.0 %). (14) Base interest rate of 13.0 %. Pursuant to the first amendment to the credit agreement entered into in August 2024, interest was paid in kind from July 1, 2024 to August 31, 2024 and then payable in cash thereafter. In November 2024, in connection with its credit facility with Private Company P, we entered into a limited waiver and amendment to such facility to waive certain failures by Private Company P to pay monthly cash interest payments when due. In connection with the waiver and amendment, Private Company P made a cash payment constituting the majority of such missed interest payments of F-18 Table of Contents approximately $ 0.3 million, with the remaining amount due capitalized into the loan balance. Cash interest payments on the facility restarted January 1, 2025. (15) Base interest rate of 8.75 % plus SOFR (SOFR floor of 5.0 %). (16) Base interest rate of 7.50 % plus SOFR (SOFR floor of 4.50 %). (17) Base interest rate of 9.50 %. (18) Base interest rate of 11.25 %. 5. LOAN RECEIVABLE HELD AT CARRYING VALUE As of December 31, 2024 and 2023, the Company’s portfolio included one loan receivable held at carrying value. The originated commitment under this loan was $ 4.0 million and outstanding principal was approximately $ 1.9 million and $ 2.0 million as of December 31, 2024 and 2023, respectively. During the year ended December 31, 2024, the Company had approximately $ 0.1 million of principal repayments of loan receivable held at carrying value. The following table presents changes in loans receivable as of and for the year ended December 31, 2024: Principal Original Issue Discount Carrying Value Total loan receivable held at carrying value at December 31, 2023 $ 2,041,744 $ ( 1,686 ) $ 2,040,058 Loan repayments ( 144,420 ) — ( 144,420 ) Total loan receivable held at carrying value at December 31, 2024 $ 1,897,324 $ ( 1,686 ) $ 1,895,638 The following table presents changes in loans receivable as of and for the year ended December 31, 2023: Principal Original Issue Discount Carrying Value Total loan receivable held at carrying value at December 31, 2022 $ 2,222,339 $ ( 1,686 ) $ 2,220,653 Loan repayments ( 180,595 ) — ( 180,595 ) Total loan receivable held at carrying value at December 31, 2023 $ 2,041,744 $ ( 1,686 ) $ 2,040,058 As of December 31, 2024 and 2023 , the Company had one loan receivable held at carrying value on nonaccrual status with an outstanding principal amount of approximately $ 1.9 million and $ 2.0 million, and amortized cost of approximately $ 1.9 million and $ 2.0 million, respectively. 6. CURRENT EXPECTED CREDIT LOSSES As of December 31, 2024 and 2023, the Company’s CECL Reserve for its loans held at carrying value and loan receivable held at carrying value is approximately $ 30.6 million and $ 26.4 million, respectively, or 10.36 % and 8.71 %, respectively, of the Company’s total loans held at carrying value and loan receivable held at carrying value of approximately $ 295.2 million and $ 303.3 million, respectively, and is bifurcated between the current expected credit loss reserve (contra-asset) related to outstanding balances on loans held at carrying value and loan receivable held at carrying value of approximately $ 30.4 million and $ 26.3 million, respectively, and a liability for unfunded commitments of approximately $ 0.2 million and $ 0.1 million, respectively. The liability was based on the unfunded portion of the loan commitment over the full contractual period over which the Company is exposed to credit risk through a current obligation to extend credit. Management considered the likelihood that funding will occur and, if funded, the expected credit loss on the funded portion. F-19 Table of Contents Activity related to the CECL Reserve for outstanding balances and unfunded commitments on the Company’s loans held at carrying value and loan receivable held at carrying value as of and for the years ended December 31, 2024 and 2023 was as follows: Outstanding (1) Unfunded (2) Total Balance at December 31, 2023 $ 26,309,450 $ 115,473 $ 26,424,923 Provision for (reversal of) current expected credit losses 4,110,227 51,229 4,161,456 Write-offs — — — Recoveries — — — Balance at December 31, 2024 $ 30,419,677 $ 166,702 $ 30,586,379 Outstanding (1) Unfunded (2) Total Balance at December 31, 2022 $ 13,538,077 $ 754,128 $ 14,292,205 Provision for (reversal of) current expected credit losses 12,771,373 ( 638,655 ) 12,132,718 Write-offs — — — Recoveries — — — Balance at December 31, 2023 $ 26,309,450 $ 115,473 $ 26,424,923 (1) As of December 31, 2024 and 2023, the CECL Reserve related to outstanding balances on loans held at carrying value and loan receivable held at carrying value is recorded within current expected credit loss reserve in the Company’s consolidated balance sheets. (2) As of December 31, 2024 and 2023, the CECL Reserve related to unfunded commitments on loans held at carrying value is recorded within current expected credit loss reserve as a liability in the Company’s consolidated balance sheets. The Company continuously evaluates the credit quality of each loan by assessing the risk factors of each loan and assigning a risk rating based on a variety of factors. Risk factors include property type, geographic and local market dynamics, physical condition, projected cash flow, loan structure and exit plan, loan-to-value ratio, fixed charge coverage ratio, project sponsorship, and other factors deemed necessary by the Company. Based on a 5-point scale, the Company’s loans are rated “1” through “5,” from less risk to greater risk, which ratings are defined as follows: Rating Definition 1 Very Low Risk — Materially exceeds performance metrics included in original or current credit underwriting and business plan 2 Low Risk — Collateral and business performance exceeds substantially all performance metrics included in original or current credit underwriting and business plan 3 Medium Risk — Collateral and business performance meets, or is on track to meet underwriting expectations; business plan is met or can reasonably be achieved 4 High Risk/ Potential for Loss — Collateral performance falls short of underwriting, material differences from business plans, defaults may exist, or may soon exist absent material improvement. Risk of recovery of interest exists 5 Impaired/ Loss Likely — Performance is significantly worse than underwriting with major variances from business plan observed. Loan covenants or financial milestones have been breached; exit from loan or refinancing is uncertain. Full recovery of principal is unlikely The risk ratings are primarily based on historical data as well as taking into account future economic conditions. F-20 Table of Contents As of December 31, 2024, the carrying value, excluding the CECL Reserve, of the Company’s loans held at carrying value and loan receivable held at carrying value within each risk rating by year of origination is as follows: Risk Rating: 2024 2023 2022 2021 2020 Total 1 $ — $ — $ — $ — $ — $ — 2 — — — — — — 3 116,544,791 27,072,247 36,202,165 24,158,987 — 203,978,190 4 — — — — — — 5 — — 11,513,143 77,771,041 1,895,638 91,179,822 Total $ 116,544,791 $ 27,072,247 $ 47,715,308 $ 101,930,028 $ 1,895,638 $ 295,158,012 7. INTEREST RECEIVABLE The following table summarizes the interest receivable by the Company as of December 31, 2024 and 2023: As of December 31 2024 2023 Interest receivable $ 1,923,914 $ 2,680,188 PIK receivable 40,000 1,009,974 Unused fees receivable 18,983 25,833 Total interest receivable $ 1,982,897 $ 3,715,995 8. INTEREST RESERVE At December 31, 2024 and 2023, the Company had zero loans that included a loan-funded interest reserve. For the years ended December 31, 2024 and 2023, approximately zero and $ 4.7 million , respectively, of aggregate interest income was earned and disbursed from the interest reserves. The following table presents changes in interest reserve as of and for the years ended December 31, 2024 and 2023: As of December 31, 2024 2023 Beginning reserves $ — $ 3,200,944 New reserves — 1,526,065 Reserves disbursed — ( 4,727,009 ) Ending reserves $ — $ — 9. DEBT Revolving Credit Facility On April 29, 2022, the Company entered into the Loan and Security Agreement (the “Revolving Credit Agreement”) by and among the Company, the other loan parties from time to time party thereto, the lenders party thereto, and the lead arranger, bookrunner and administrative agent party thereto, pursuant to which, the Company obtained a $ 60.0 million senior secured revolving credit facility (as amended from time to time, the “Revolving Credit Facility”). The Revolving Credit Facility has a maturity date of April 29, 2025. The Revolving Credit Facility contains aggregate commitments of $ 60.0 million from two FDIC-insured banking institutions (which may be increased to up to $ 100.0 million in aggregate, subject to available borrowing base and additional commitments) which may be borrowed, repaid and redrawn, subject to a borrowing base based on eligible loan obligations held by the Company and subject to the satisfaction of other conditions provided under the Revolving Credit Facility. Interest is payable on the Revolving Credit Facility at the greater of (1) the applicable base rate plus 0.50 % and (2) 4.50 %, as provided in the Revolving Credit Agreement, payable in cash in arrears. Upon entering into the Revolving Credit F-21 Table of Contents Agreement, the Company incurred a one-time commitment fee expense of approximately $ 0.5 million, which was included in prepaid expenses and other assets on the Company’s consolidated balance sheets and amortized over the life of the facility. Commencing on the six-month anniversary of the closing date, the Revolving Credit Facility has an unused line fee of 0.25 % per annum, payable semi-annually in arrears, which is included within interest expense in the Company’s consolidated statements of operations. Based on the terms of the Revolving Credit Agreement, the Company’s estimated average cash balance will exceed the minimum balance required to waive the unused line fee and as such, the Company did not incur an unused line fee during the year ended December 31, 2024. As of December 31, 2024 and 2023, outstanding borrowings under the Revolving Credit Facility were $ 60.0 million and $ 42.0 million, respectively, and zero and $ 18.0 million was available for borrowing as of December 31, 2024 and 2023, respectively. As of December 31, 2024, the interest rate on the Company’s borrowings under the Revolving Credit Facility was 8.00 %. The obligations of the Company under the Revolving Credit Facility are secured by certain assets of the Company comprising of or relating to loan obligations designated for inclusion in the borrowing base. In addition, the Company is subject to various financial and other covenants, including: (1) liquidity of at least $ 5.0 million, (2) annual debt service coverage of at least 1.5 to 1.0 and (3) secured debt not to exceed 25 % of total consolidated assets of the Company and its subsidiaries. To the best of our knowledge, as of December 31, 2024, we were in compliance in all material respects with all covenants contained in our Revolving Credit Agreement. In March 2024, the Company entered into Amendment Number One to Loan and Security Agreement, by and among the Company, as borrower, the lenders party thereto and the lead arranger, bookrunner and administrative agent party thereto, pursuant to which, among other things, the parties agreed expand the borrowing base to include funds maintained in a borrowing base cash account. In July 2024, the Company entered into Amendment Number Two to Loan and Security Agreement, by and among the Company, as borrower, the lenders party thereto, and the lead arranger, bookrunner and administrative agent party thereto, pursuant to which, among other things, the parties agreed to exclude certain subsidiaries from the calculation of certain financial covenants so long as such subsidiaries are considered immaterial under the terms of the Loan and Security Agreement. In January 2025, the Company entered into Amendment Number Three to Loan and Security Agreement, by and among the Company, as borrower, the lenders party thereto, and the lead arranger, bookrunner and administrative agent party thereto, pursuant to which, among other things, the parties agreed to reduce the procedural requirements for obligor loan receivables to become eligible under the borrowing base. AFCF Credit Facility In December 2024, the Company entered into an unsecured revolving credit agreement (the “AFCF Credit Agreement”), by and among the Company, as borrower, the lenders party thereto from time to time, and AFC Finance, LLC, as agent and lender. AFC Finance, LLC is wholly owned by Leonard M. Tannenbaum, Chairman of the Company’s Board of Directors. The AFCF Credit Agreement provides for an unsecured revolving credit facility (the “AFCF Credit Facility”) with a $ 40.0 million commitment, which may be borrowed, repaid and redrawn, subject to a draw fee and the other conditions provided in the AFCF Credit Agreement. Interest is payable on the AFCF Credit Facility at a rate per annum equal to 8.00 %. The AFCF Credit Facility matures on the earlier of (i) December 31, 2025 and (ii) the date of the closing of any unsecured debt with principal of at least $ 40.0 million used to refinance the AFCF Credit Agreement. As of December 31, 2024, outstanding borrowings under the AFCF Credit Facility were $ 40.0 million and zero was available for borrowing as of December 31, 2024. As of December 31, 2024, the interest rate on the Company’s borrowings under the AFCF Credit Facility was 8.00 %. 2027 Senior Notes On November 3, 2021, the Company issued $ 100.0 million in aggregate principal amount of senior unsecured notes due in May 2027 (the “2027 Senior Notes”). The 2027 Senior Notes accrue interest at a rate of 5.75 % per annum. Interest on the 2027 Senior Notes is due semi-annually on May 1 and November 1 of each year, which began on May 1, 2022. The net proceeds from the offering were approximately $ 97.0 million, after deducting the initial purchasers’ discounts and commissions and estimated offering fees and expenses payable by the Company. The Company used the proceeds from the issuance of the 2027 Senior Notes (i) to fund loans related to unfunded commitments to existing borrowers, (ii) to originate and participate in commercial loans to companies operating in the cannabis industry that are consistent with the Company’s investment strategy and (iii) for working capital and other general corporate purposes. The terms of the 2027 Senior Notes are governed by an indenture, dated November 3, 2021, among us, as issuer, and TMI Trust Company, as trustee (the “Indenture”). F-22 Table of Contents Under the Indenture, the Company is required to cause all of its existing and future subsidiaries to guarantee the 2027 Senior Notes, other than certain immaterial subsidiaries as set forth in the Indenture. TRS1 is currently a subsidiary guarantor under the Indenture. Prior to February 1, 2027, the Company may redeem the 2027 Senior Notes in whole or in part, at a price equal to the greater of 100 % of the principal amount of the 2027 Senior Notes being redeemed or a make-whole premium set forth in the Indenture, plus accrued and unpaid interest thereon to, but excluding, the applicable redemption date. On or after February 1, 2027, we may redeem the 2027 Senior Notes in whole or in part at a price equal to 100 % of the principal amount of the 2027 Senior Notes being redeemed, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date. The Indenture also requires us to offer to purchase all of the 2027 Senior Notes at a purchase price equal to 101 % of the principal amount of the 2027 Senior Notes, plus accrued and unpaid interest if a “change of control triggering event” (as defined in the Indenture) occurs. The Indenture contains customary terms and restrictions, subject to a number of exceptions and qualifications, including restrictions on the Company’s ability to (1) incur additional indebtedness unless the Annual Debt Service Charge (as defined in the Indenture) is no less than 1.5 to 1.0, (2) incur or maintain total debt in an aggregate principal amount greater than 60 % of the Company’s consolidated Total Assets (as defined in the Indenture), (3) incur or maintain secured debt in an aggregate principal amount greater than 25 % of the Company’s consolidated Total Assets (as defined in the Indenture), and (4) merge, consolidate or sell substantially all of the Company’s assets. In addition, the Indenture also provides for customary events of default. If any event of default occurs, any amount then outstanding under the Indenture may immediately become due and payable. These events of default are subject to a number of important exceptions and qualifications set forth in the Indenture. During the year ended December 31, 2023 , the Company repurchased $ 10.0 million in principal amount of the Company’s 2027 Senior Notes at 77.4 % of par value, plus accrued interest. This resulted in a gain on extinguishment of debt of approximately $ 2.0 million, recorded within the consolidated statements of operations. No repurchases took place during the year ended December 31, 2024. As of December 31, 2024 and 2023 , the Company had $ 90.0 million in principal amount of the 2027 Senior Notes outstanding. As of December 31, 2024, the interest rate on the Company’s borrowings under the 2027 Senior Notes was 5.75 % The 2027 Senior Notes are due on May 1, 2027. Scheduled principal payments on the 2027 Senior Notes as of December 31, 2024 are as follows: 2027 Senior Notes Year 2025 $ — 2026 — 2027 90,000,000 2028 — 2029 — Thereafter — Total principal 90,000,000 Deferred financing costs included in senior notes ( 1,387,850 ) Total due senior notes, net $ 88,612,150 The following tables reflect a summary of interest expense incurred during the years ended December 31, 2024 and 2023: F-23 Table of Contents Year ended December 31, 2024 2027 Senior Notes Revolving Credit Facility AFCF Revolving Credit Facility Total Borrowings Interest expense $ 5,175,000 $ 117,387 $ 18,778 $ 5,311,165 Amortization of deferred financing costs 632,592 392,551 — 1,025,143 Total interest expense $ 5,807,592 $ 509,938 $ 18,778 $ 6,336,308 Year ended December 31, 2023 2027 Senior Notes Revolving Credit Facility AFCF Revolving Credit Facility Total Borrowings Interest expense $ 5,290,000 $ 68,667 $ — $ 5,358,667 Unused fee expense — 47,915 — 47,915 Amortization of deferred financing costs 641,662 309,213 — 950,875 Total interest expense $ 5,931,662 $ 425,795 $ — $ 6,357,457 10. COMMITMENTS AND CONTINGENCIES As of December 31, 2024 and 2023, the Company had the following commitments to fund various investments: As of December 31, 2024 2023 Total loan commitments $ 361,278,431 $ 431,239,913 Less: drawn commitments ( 350,943,832 ) ( 421,239,913 ) Total undrawn commitments $ 10,334,599 $ 10,000,000 The Company from time to time may be a party to litigation in the normal course of business. As of December 31, 2024, the Company is not aware of any legal claims that could materially impact its business, financial condition or results of operations. On March 17, 2023, the Company appointed Brandon Hetzel to serve as its Chief Financial Officer and Treasurer in place of Brett Kaufman, effective as of such date, with Mr. Kaufman’s employment with AFC Management, LLC, the Company’s external manager (the “Manager”), terminated, effective as of April 17, 2023 (the “Separation Date”). In connection with his termination, Mr. Kaufman received (i) twelve (12) months’ worth of his current base salary, (ii) his annual target bonus, (iii) continued payment by our Manager of 100 % of the COBRA premiums for him and his dependents for a period of twelve (12) months following his Separation Date, (iv) accelerated vesting of one ( 1 ) additional tranche of each of Mr. Kaufman’s outstanding equity awards, and (v) extension of the exercise period for Mr. Kaufman’s outstanding options until one (1) year following the Separation Date, contingent on Mr. Kaufman executing and not revoking a release of claims in favor of the Company. During the year ended December 31, 2024 and 2023 , the Company recorded zero and approximately $ 0.7 million in severance expense within general and administrative expenses within the consolidated statements of operations, respectively. The Company provides loans to companies operating in the cannabis industry which involves significant risks, including the risk of strict enforcement against the Company’s borrowers on the federal illegality of cannabis, the Company’s borrowers’ inability to renew or otherwise maintain their licenses or other requisite authorizations for their cannabis operations, and such loans lack of liquidity, and the Company could lose all or part of any of the Company’s loans. F-24 Table of Contents The Company’s ability to grow or maintain its business with respect to the loans it makes to companies operating in the cannabis industry depends on state laws pertaining to the cannabis industry. New laws that are adverse to the Company’s borrowers may be enacted, and current favorable state or national laws or enforcement guidelines relating to cultivation, production and distribution of cannabis may be modified or eliminated in the future, which would impede the Company’s ability to grow and could materially adversely affect the Company’s business. Management’s plan to mitigate risks include monitoring the legal landscape as deemed appropriate. Also, should a loan default or otherwise be seized, the Company may be prohibited from owning cannabis assets and thus could not take possession of collateral, in which case the Company would look to sell the loan, which could result in the Company realizing a loss on the transaction. 11. SHAREHOLDERS’ EQUITY Series A Preferred Stock As of December 31, 2024 and 2023, the Company has authorized 10,000 preferred shares and previously issued 125 of the preferred shares designated as 12.0 % Series A Cumulative Non-Voting Preferred Stock, par value $ 0.01 per share (the “Series A Preferred Stock”). As of December 31, 2024 and December 31, 2023, there were zero and 125 shares of Series A Preferred Stock issued and outstanding, respectively. The Series A Preferred Stock entitles the holders thereof to receive cumulative cash dividends at a rate per annum of 12.0 % of the liquidation preference of $ 1,000 per share plus all accumulated and unpaid dividends thereon. The Company generally may not declare or pay, or set apart for payment, any dividend or other distribution on any shares of the Company’s stock ranking junior to the Series A Preferred Stock as to dividends, including the Company’s common stock, or redeem, repurchase or otherwise make payments on any such shares, unless full, cumulative dividends on all outstanding shares of Series A Preferred Stock have been declared and paid or set apart for payment for all past dividend periods. The holders of the Series A Preferred Stock generally have no voting rights except in limited circumstances, including certain amendments to the Company’s charter and the authorization or issuance of equity securities senior to or on parity with the Series A Preferred Stock. The Series A Preferred Stock is not convertible into shares of any other class or series of our stock. The Series A Preferred Stock is senior to all other classes and series of shares of the Company’s stock as to dividend and redemption rights and rights upon the Company’s liquidation, dissolution and winding up. Upon written notice to each record holder of the Series A Preferred Stock as to the effective date of redemption, the Company may redeem the shares of the outstanding Series A Preferred Stock at the Company’s option, in whole or in part, at any time for cash at a redemption price equal to $ 1,000 per share, plus all accrued and unpaid dividends thereon up to and including the date fixed for redemption. Shares of the Series A Preferred Stock that are redeemed shall no longer be deemed outstanding shares of the Company and all rights of the holders of such shares will terminate. On June 30, 2024, the Company redeemed all 125 outstanding shares of its Series A Preferred Stock. The Series A Preferred Stock was redeemed at a price of $ 1,000 per share, plus all accrued and unpaid dividends thereon to and including the date fixed for redemption. As the shares were redeemed on June 30, 2024, there were no accrued and unpaid dividends. Common Stock During the year ended December 31, 2024 and 2023 , the Company did not issue any shares of its common stock, other than shares of common stock sold under the ATM Program (hereinafter defined) and restricted stock awards granted under the 2020 Plan. Shelf Registration Statement On April 5, 2022, the Company filed a shelf registration statement on Form S-3 (File No. 333-264144) (the “Shelf Registration Statement”), which was declared effective on April 18, 2022. Under the Shelf Registration Statement, the Company may, from time to time, issue and sell up to $ 1.0 billion of the Company’s common stock, preferred stock, debt securities, warrants and rights (including as part of a unit) to purchase shares of the Company’s common stock or preferred stock. F-25 Table of Contents At-the-Market Offering Program (“ATM Program”) On April 5, 2022, the Company entered into an Open Market Sales Agreement (the “Sales Agreement”) with Jefferies LLC and Citizens JMP Securities LLC, as Sales Agents, under which the Company may, from time to time, offer and sell shares of common stock, having an aggregate offering price of up to $ 75.0 million. Under the terms of the Sales Agreement, the Company has agreed to pay the Sales Agents a commission of up to 3.0 % of the gross proceeds from each sale of common stock sold through the Sales Agents. Sales of common stock, if any, may be made in transactions that are deemed to be “at-the-market” offerings, as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the “Securities Act”). During the year ended December 31, 2024, the Company sold an aggregate of 1,582,960 shares of the Company’s common stock under the Sales Agreement at a weighted average price of $ 10.24 per share, generating net proceeds of approximately $ 15.6 million. As of December 31, 2024, the Company’s remaining authorization under the Sales Agreement was approximately $ 47.4 million. As of December 31, 2024 , the shares of common stock sold under the ATM Program are the only offerings that have been initiated under the Shelf Registration Statement. Stock Incentive Plan The Company has established a stock incentive compensation plan (the “2020 Plan”). The 2020 Plan authorizes stock options, stock appreciation rights, restricted stock, stock bonuses, stock units and other forms of awards granted or denominated in the Company’s common stock or units of common stock. The 2020 Plan retains flexibility to offer competitive incentives and to tailor benefits to specific needs and circumstances. Any award may be structured to be paid or settled in cash. The Company has granted, and currently intends to continue to continue to grant, stock options and restricted stock awards to participants in the 2020 Plan, but it may also grant any other type of award available under the 2020 Plan in the future. Persons eligible to receive awards under the 2020 Plan include officers or employees of the Company or any of its subsidiaries, directors of the Company, employees of the Manager and certain directors, consultants and other service providers to the Company or any of its subsidiaries. In December 2024, the Company’s Board of Directors approved grants of 82,873 shares of restricted stock to Daniel Neville, the Company’s CEO, which vest over a three-year period with approximately 33 % vesting on each of the first, second and third anniversaries of December 20, 2024. In January 2024, the Company’s Board of Directors approved grants of restricted stock to the Company’s directors and certain officers, as well as certain employees of the Manager, with an aggregate of 209,397 shares of restricted stock granted to such eligible persons. The restricted stock granted in January 2024 under the 2020 Plan contain vesting periods that vary from immediately vested to vesting over a three-year period, with approximately 33 % vesting on each of the first, second and third anniversaries of the vesting commencement date. In January 2023, the Company’s Board of Directors approved grants of restricted stock to the Company’s directors and certain officers, as well as certain employees of the Manager, with an aggregate of 125,234 shares of restricted stock granted to such eligible persons. The restricted stock granted in January 2023 under the 2020 Plan contain vesting periods that vary from immediately vested to vesting over a three-year period, with approximately 33 % vesting on each of the first, second and third anniversaries of the vesting commencement date. In June 2023, the Company granted 1,159 shares of restricted stock to James C. Fagan in connection with his appointment to the Company’s Board of Directors, which vested upon the one-year anniversary of the grant date. As of December 31, 2024, there were 2,618,662 shares of common stock granted under the 2020 Plan, underlying 2,169,352 options and 449,310 shares of restricted stock. As of December 31, 2024, the maximum number of shares of the Company’s common stock that may be delivered pursuant to awards under the 2020 Plan (the “Share Limit”) equaled 3,609,722 shares, of which 991,060 shares remained available for future issuance under the 2020 Plan. The Share Limit increased during the year ended December 31, 2024 under the evergreen provision in the 2020 Plan in connection with the shares issued under the ATM Program during such time and in connection with the Minimum Annual Increase (as defined in the 2020 Plan) under the 2020 Plan for the 2024 fiscal year. Shares that are subject to or underlie awards that expire or, for any reason, are cancelled, terminated, forfeited, fail to vest or are not paid or delivered under the 2020 Plan will not be counted against the Share Limit and will again be available for subsequent awards under the 2020 Plan. F-26 Table of Contents Modification of Stock Options and Restricted Stock Outstanding at Spin-Off Stock Options On July 9, 2024, the Company completed the separation of its CRE portfolio through the Spin-Off of SUNS. As a result, the strike price for the outstanding stock options of the Company were adjusted to give effect to the Spin-Off. All adjustments were made with the intent to preserve the intrinsic value of each award immediately before and after the Spin-Off. The Company accounted for the modification as Type I modification (probable to probable). The number of awards remained constant, while the strike prices were modified to preserve the intrinsic value of each award. The modified stock option awards otherwise retained substantially the same terms and conditions, including term and vesting provisions. The fair value of such unvested stock option awards remained constant pre- and post-Spin-Off, resulting in no incremental compensation cost. The Company will recognize the remaining unrecognized compensation cost of the original stock option awards over the remaining vesting period. The Company used the Black-Scholes option pricing model to value stock options in determining the stock-based compensation expense. The Company has elected to recognize forfeitures as they occur. Previously recognized compensation expense related to forfeitures are reversed in the period the nonvested awards are forfeited. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The expected dividend yield was based on the Company’s expected dividend yield at the grant date. Expected volatility is based on the estimated average volatility of similar companies due to the lack of historical volatilities of the Company’s common stock. The expected term for each award is based on the contractual term for all awards granted thus far under the 2020 Plan. Restricted stock grant expense is based on the Company’s stock price at the time of the grant and amortized over the vesting period. The weighted-average exercise price of stock options have been retroactively adjusted to give effect to the Spin-Off for all periods presented. The following table presents the assumptions used in the Black-Scholes pricing model of options granted under the 2020 Plan during the years ended December 31, 2024 and 2023: Assumptions: Range Expected term 7.0 years Expected volatility 40 % - 50 % Expected dividend yield 10 % - 20 % Risk-free interest rate 0.5 % - 2.0 % Expected forfeiture rate 0 % The modification date fair value of the stock options was determined using the Binomial-Lattice Model with the following assumptions on July 9, 2024: Assumptions: Range Expected term 3.1 - 4.5 years Expected volatility 31.24 % - 32.41 % Expected dividend yield 15.65 % Risk-free interest rate 4.16 % - 4.25 % Expected forfeiture rate 0 % As additional Company history and information is available, the Company determined the use of the Binomial-Lattice Model to be appropriate compared to the closed-form Black-Scholes model. The risk-free interest rate is based on the continuously compounded rates from the U.S. Treasury yield curve in effect at the date of Spin-Off. The expected term is based on the remaining contractual term of each option’s life as of the date of Spin-Off. The expected dividend yield was based on the Company’s most recent quarterly dividend divided by the three-month average stock price as of the Spin-Off date, annualized. Expected volatility is based on the remaining contractual term-matched historical volatility. In cases where the look back period exceeds the trading history of the Company’s Common Stock, the Company’s entire trading history was used. F-27 Table of Contents Restricted Stock Restricted stock awards originally granted under the 2020 Plan include awards granted to employees of the Company’s manager that perform shared fun ctions pre- and post-Spin-Off. In co nnection with the Spin-Off transaction and as a result of the related modification, approximately 33 % of the remaining unrecognized compensation cost of unvested restricted stock awards will be recognized over the remaining vesting period of the Company’s former wholly-owned subsidiary, SUNS. The Company will recognize the remaining 67 % of unrecognized compensation cost of unvested restricted stock awards over the remaining vesting period. Stock Compensation The following table summarize s the stock-based compensation expense incurred by the Company for the years ended December 31, 2024 and 2023: Years ended December 31, 2024 2023 Stock-based compensation $ 1,390,978 $ 1,008,148 Stock Options The following table summarizes the (i) non-vested options granted, (ii) vested options granted, (iii) exercised and (iv) forfeited options granted for the Company’s directors and officers and employees of the Manager as of December 31, 2024 and 2023: As of December 31, 2024 2023 Non-vested 149,133 206,304 Vested 2,225,499 2,168,328 Exercised ( 5,511 ) ( 5,511 ) Forfeited ( 200,669 ) ( 200,169 ) Balance 2,168,452 2,168,952 The following tables summarize stock option activity as of and during the year ended December 31, 2024: Number of options Weighted-average exercise price Weighted-average remaining contractual term Aggregate intrinsic value Outstanding as of December 31, 2023 2,168,952 $ 11.46 Granted — — Exercised — — Forfeited ( 500 ) 12.99 Outstanding as of December 31, 2024 2,168,452 $ 11.46 3.27 years $ — Exercisable as of December 31, 2024 2,136,176 $ 11.44 3.26 years $ — Unvested as of December 31, 2024 32,276 $ 12.86 3.87 years $ — T he Company did not grant any options d uring the year ended December 31, 2024 and 2023 . No options were exercised during the year ended December 31, 2024 and 2023 . As of December 31, 2024 , there was approximately $ 16.1 thousand of total unrecognized compensation cost related to stock options, which is expected to be recognized over a weighted-average period of 0.96 years. F-28 Table of Contents Restricted Stock The following table summarizes restricted stock (i) granted, (ii) vested and (iii) forfeited for the Company’s directors and officers and employees of the Manager as of December 31, 2024 and 2023: As of December 31, 2024 2023 Granted 483,244 190,974 Vested ( 102,780 ) ( 38,028 ) Forfeited ( 33,934 ) ( 33,934 ) Balance 346,530 119,012 The following tables summarize the restricted stock activity as of and during the year ended December 31, 2024: Number of shares of restricted stock Weighted-average grant date fair value (1) Balance as of December 31, 2023 119,012 $ 16.06 Granted 292,270 10.95 Vested ( 64,752 ) 14.50 Forfeited — — Balance as of December 31, 2024 346,530 $ 8.72 (1) The fair value of the Company’s restricted stock awards is based on the Company’s stock price on the date of grant. The weighted-average grant date fair value of the remaining unvested restricted stock awards as of December 31, 2024 has been adjusted to give effect to the Spin-Off transaction, which was completed July 9, 2024. The total fair value of shares vested during the year ended December 31, 2024 and 2023, was approximately $ 0.8 million and $ 0.5 million, respectively. During the year ended December 31, 2023, 126,393 shares of restricted stock were granted with a weighted-average grant date fair value of $ 15.55 . During the year ended December 31, 2023, 38,028 shares of restricted stock vested with a weighted-average grant date fair value of $ 18.03 . As of December 31, 2024 , there was approximately $ 2.1 million of total unrecognized compensation cost related to non-vested restricted stock. That cost is expected to be recognized over a weighted-average period of 2.15 years. F-29 Table of Contents 12. EARNINGS PER SHARE The following information sets forth the computations of basic and diluted weighted average earnings per common share for the years ended December 31, 2024 and 2023: Years ended December 31, 2024 2023 Net income from continuing operations $ 13,862,137 $ 20,717,377 Dividends paid on preferred stock ( 7,500 ) ( 15,000 ) Dividends paid on unvested restricted stock ( 440,028 ) ( 262,394 ) Net income from continuing operations attributable to common shareholders 13,414,609 20,439,983 Net income from discontinued operations 2,922,068 234,622 Net income attributable to common shareholders 16,336,677 20,674,605 Divided by: Basic weighted average shares of common stock outstanding 20,821,239 20,321,091 Weighted average unvested restricted stock and dilutive stock options 67,741 24,828 Diluted weighted average shares of common stock outstanding 20,888,980 20,345,919 Basic earnings per share Continuing operations $ 0.64 $ 1.01 Discontinued operations $ 0.14 $ 0.01 Total basic weighted average earnings per common share $ 0.78 $ 1.02 Diluted earnings per share Continuing operations $ 0.64 $ 1.01 Discontinued operations $ 0.14 $ 0.01 Total diluted weighted average earnings per common share $ 0.78 $ 1.02 Diluted earnings per share was computed using the treasury stock method for stock options and restricted stock. Diluted weighted average earnings per common share excluded 1,499,209 and 2,336,146 weighted average unvested restricted stock and stock options due to anti-dilutive effect for the years ended December 31, 2024 and 2023, respectively . 13. INCOME TAX A TRS is an entity taxed as a corporation that has not elected to be taxed as a REIT, in which a REIT directly or indirectly holds equity, and that has made a joint election with such REIT to be treated as a TRS. A TRS generally may engage in any business, including investing in assets and engaging in activities that could not be held or conducted directly by the Company without jeopardizing its qualification as a REIT. A TRS is subject to applicable United States federal, state and local income tax on its taxable income. In addition, as a REIT, the Company also may be subject to a 100% excise tax on certain transactions between it and its TRS that are not conducted on an arm’s-length basis. The income tax provision is included in the line item income tax expense, including excise tax. The income tax provision for the Company was approximately $ 0.4 million and $ 1.7 million for the years ended December 31, 2024 and 2023, respectively. The income tax expense for the years ended December 31, 2024 and 2023 primarily related to activities of the Company’s taxable REIT subsidiary. F-30 Table of Contents The income tax provision for the Company and TRS1 consisted of the following for the years ended December 31, 2024 and 2023: Years ended December 31, 2024 2023 Current: Federal $ 868,300 $ 1,239,878 State 298,894 306,338 Total current income tax expense (benefit) 1,167,194 1,546,216 Deferred: Federal ( 711,653 ) — State — — Total deferred income tax (benefit) expense ( 711,653 ) — Excise tax ( 7,954 ) 113,121 Total income tax expense (benefit), including excise tax $ 447,587 $ 1,659,337 For the years ended December 31, 2024 and 2023, the Company incurred zero and $ 0.1 million for United States federal excise tax expense, respectively. Excise tax represents a 4 % tax on the sum of a portion of the Company’s ordinary income and net capital gains not distributed during the period. If it is determined that an excise tax liability exists for the current period, the Company will accrue excise tax on estimated excess taxable income as such taxable income is earned. The expense is calculated in accordance with applicable tax regulations. The Company does not have any unrecognized tax benefits and the Company does not expect that to change in the next 12 months. The following table is a reconciliation of the income tax computed for continuing operations at the federal statutory rate of 21% for the years ended December 31, 2024 and 2023: Years ended December 31, 2024 2023 U.S. federal statutory tax rate 21.0 % 21.0 % State and local income taxes, net of federal income tax effect 0.8 % 0.7 % REIT income not subject to corporate income tax ( 18.7 ) % ( 18.4 ) % Nontaxable items temporary differences ( 1.9 ) % 0.0 % Federal excise tax 0.0 % 0.2 % Effective tax rate 1.2 % 3.5 % The primary difference between the Company’s statutory rate and effective tax rate is largely determined by the amount of income subject to tax by the Company’s taxable REIT subsidiary . The Company expects that its future effective tax rate will be determined in a similar manner. As of December 31, 2024 and 2023, the Company’s deferred tax assets were $ 0.7 million and zero , respectively, and are included in prepaid expenses and other assets in the Company’s consolidated balance sheets. The Company believes it is more likely than not that the deferred tax assets will be realized in the future. Realization of the deferred tax assets is dependent upon the Company’s generation of sufficient taxable income in future years in appropriate tax jurisdictions to benefit from the reversal of temporary differences. The amount of deferred tax assets considered realizable is subject to adjustment in future periods if estimates of future taxable income change. The Company recorded deferred tax assets related to temporary differences on the fair value adjustments of the unrealized losses of loans held in the TRS and CECL allowance on loans held in the TRS. There were no valuation allowances for deferred tax assets during the years ended December 31, 2024 and 2023. F-31 Table of Contents 14. FAIR VALUE Loans Held for Investment The Company’s loans are typically valued using a yield analysis, which is typically performed for non-credit impaired loans to borrowers where the Company does not own a controlling equity position. Alternative valuation methodologies may be used as appropriate, and can include a market analysis, income analysis, or recovery analysis. To determine fair value using a yield analysis, a current price is imputed for the loan based upon an assessment of the expected market yield for a similarly structured loan with a similar level of risk. In the yield analysis, the Company considers the current contractual interest rate, the maturity and other terms of the loan relative to risk of the company and the specific loan. A key determinant of risk, among other things, is the leverage through the loan relative to the enterprise value of the borrower. As loans held by the Company are substantially illiquid with no active loan market, the Company depends on primary market data, including newly funded loans, as well as secondary market data with respect to high-yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. The following tables present fair value measurements of loans held at fair value as of December 31, 2024 and 2023: Fair Value Measurement as of December 31, 2024 Total Level 1 Level 2 Level 3 Loans held at fair value $ 30,510,804 $ — $ — $ 30,510,804 Total $ 30,510,804 $ — $ — $ 30,510,804 Fair Value Measurement as of December 31, 2023 Total Level 1 Level 2 Level 3 Loans held at fair value $ 61,720,705 $ — $ — $ 61,720,705 Total $ 61,720,705 $ — $ — $ 61,720,705 The following table presents changes in loans that use Level 3 inputs as of and for the year ended December 31, 2024: Year ended December 31, 2024 Total loans using Level 3 inputs at December 31, 2023 $ 61,720,705 Change in unrealized (losses) gains on loans at fair value, net ( 9,806,916 ) Additional fundings 4,594,027 Original issue discount and other discounts, net of costs ( 2,756,416 ) Loan repayments ( 5,218,919 ) Sale of loans ( 19,284,846 ) Accretion of original issue discount 128,384 PIK interest 1,134,785 Total loans using Level 3 inputs at December 31, 2024 $ 30,510,804 The change in unrealized losses included in the consolidated statements of operations attributable to loans held at fair value, categorized as Level 3, held as of December 31, 2024 is $( 14,232,926 ). The following tables summarize the significant unobservable inputs the Company used to value the loans categorized within Level 3 as of December 31, 2024 and 2023. The tables are not intended to be all-inclusive, but instead capture the significant unobservable inputs relevant to the Company’s determination of fair values. As of December 31, 2024 Unobservable Input Fair Value Primary Valuation Techniques Input Estimated Range Weighted Average Senior term loan $ 30,510,804 Recovery analysis Recovery rate 54.90 % - 60.00 % 57.45 % Total investment $ 30,510,804 F-32 Table of Contents As of December 31, 2023 Unobservable Input Fair Value Primary Valuation Techniques Input Estimated Range Weighted Average Senior term loans $ 47,627,845 Recovery analysis Recovery rate 86.10 % - 92.40 % 89.25 % Senior term loans 14,092,860 Market approach Revenue multiple 0.50 x - 0.70 x 0.60 x Total investments $ 61,720,705 Changes in market yields, revenue multiples, and recovery rates may change the fair value of certain of the Company’s loans. Generally, an increase in market yields may result in a decrease in the fair value of certain of the Company’s loans, while a decrease in revenue multiples and recovery rates may result in a decrease in the fair value of certain of the Company’s loans. Due to the inherent uncertainty of determining the fair value of loans that do not have a readily available market value, the fair value of the Company’s loans may fluctuate from period to period. Additionally, the fair value of the Company’s loans may differ significantly from the values that would have been used had a ready market existed for such loans and may differ materially from the values that the Company may ultimately realize. Further, such loans are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If the Company was required to liquidate a loan in a forced or liquidation sale, it could realize significantly less than the value at which the Company has recorded it. In addition, changes in the market environment and other events that may occur over the life of the loans may cause the gains or losses ultimately realized on these loans to be different than the unrealized gains or losses reflected in the valuations currently assigned. Fair Value of Financial Instruments GAAP requires disclosure of fair value information about financial instruments, whether or not recognized at fair value in the balance sheets, for which it is practicable to estimate that value. The following table details the book value and fair value of the Company’s financial instruments not recognized at fair value in the consolidated balance sheets as of December 31, 2024 : As of December 31, 2024 Carrying Value Fair Value Financial assets: Cash and cash equivalents $ 103,610,460 $ 103,610,460 Loans held for investment at carrying value $ 293,262,374 $ 264,774,699 Loan receivable held at carrying value $ 1,895,638 $ — Financial liabilities: Senior notes payable, net $ 88,612,150 $ 85,455,000 Estimates of fair value for cash and cash equivalents are measured using observable, quoted market prices, or Level 1 inputs. The Company’s loans held for investment are measured using unobservable inputs, or Level 3 inputs. The fair value of the Company’s 2027 Senior Notes is estimated using observable inputs based on the last available bid price in the market at the end of the period, or Level 2 inputs. 15. RELATED PARTY TRANSACTIONS Management Agreement Pursuant to the Management Agreement, the Manager manages the loans and day-to-day operations of the Company, subject at all times to the further terms and conditions set forth in the Management Agreement and such further limitations or parameters as may be imposed from time to time by the Company’s Board. F-33 Table of Contents The Manager receives base management fees (the “Base Management Fee”) that are calculated and payable quarterly in arrears, in an amount equal to 0.375 % of the Company’s Equity (as defined in the Management Agreement), subject to certain adjustments, less 50 % of the aggregate amount of any other fees (“Outside Fees”), including any agency fees relating to our loans, but excluding the Incentive Compensation (as defined below) and any diligence fees paid to and earned by the Manager and paid by third parties in connection with the Manager’s due diligence of potential loans. In addition to the Base Management Fee, the Manager is entitled to receive incentive compensation (the “Incentive Compensation” or “Incentive Fees”) under the Management Agreement. Under the Management Agreement, the Company pays Incentive Fees to the Manager based upon the Company’s achievement of targeted levels of Core Earnings. “Core Earnings” is defined in the Management Agreement as, for a given period, the net income (loss) for such period, computed in accordance with GAAP, excluding (i) non-cash equity compensation expense, (ii) the Incentive Compensation, (iii) depreciation and amortization, (iv) any unrealized gains or losses or other non-cash items that are included in net income for the applicable reporting period, regardless of whether such items are included in other comprehensive income or loss, or in net income and (v) one-time events pursuant to changes in GAAP and certain non-cash charges, in each case after discussions between the Manager and the Company’s independent directors and approved by a majority of the independent directors. The Incentive Compensation for the years ended December 31, 2024 and 2023 , was approximately $ 6.8 million and $ 10.4 million, respectively. The Company is required to pay all of its costs and expenses and reimburse the Manager or its affiliates for expenses of the Manager and its affiliates paid or incurred on behalf of the Company, excepting only those expenses that are specifically the responsibility of the Manager pursuant to the Management Agreement. With respect to certain office expenses incurred by the Manager on behalf of the Company and other funds managed by the Manager or its affiliates, such as rent, the Manager determines each fund’s pro rata portion of such expenses in an amount equal to the proportional amount of time employees of the Manager spent providing services to the Company, as reasonably stipulated by time sheets. The following table summarizes the related party costs incurred by the Company for the years ended December 31, 2024 and 2023 : Years ended December 31, 2024 2023 Affiliate Costs Management fees $ 4,541,310 $ 5,395,617 Less: outside fees earned ( 947,969 ) ( 1,693,133 ) Base management fees 3,593,341 3,702,484 Incentive fees earned 6,768,480 10,361,821 General and administrative expenses reimbursable to Manager 2,914,256 3,590,594 Total $ 13,276,077 $ 17,654,899 Amounts payable to the Company’s Manager as of December 31, 2024 and 2023 were approximately $ 3.1 million and $ 5.0 million, respectively. The Manager is a wholly-owned subsidiary of Castleground Holdings LLC (f/k/a Advanced Flower Capital Management, LLC) (the “Parent Manager”). As of December 31, 2024, certain officers have ownership in the outstanding equity of the Parent Manager, including Leonard Tannenbaum, Chairman of the Board, Robyn Tannenbaum, President and Chief Investment Officer, Bernard Berman, a member of the Company’s Investment Committee, and Daniel Neville, Chief Executive Officer. Due to Affiliate Amounts due to an affiliate of the Company as of December 31, 2024 and 2023 were approximately $ 6.8 thousand and $ 16.4 thousand, respectively. F-34 Table of Contents Investments in Loans From time to time, the Company may co-invest with other investment vehicles managed by the Manager or its affiliates, including the Manager, and their portfolio companies, including by means of splitting loans, participating in loans or other means of syndicating loans. The Company is not obligated to provide, nor has it provided, any financial support to the other managed investment vehicles. As such, the Company’s risk is limited to the carrying value of its investment in any such loan. Additionally, the Company’s Manager or its affiliates, including AFC Agent LLC (“AFC Agent”), may from time to time serve as administrative and collateral agent to the lenders under the Company’s loans. As of December 31, 2024, there were two co-invested loans held by the Company and affiliates of the Company. Unsecured Revolving Credit Facility with Affiliate The Company entered the Revolving Credit Facility with AFC Finance LLC, an affiliate of the Company and Mr. and Mrs. Tannenbaum. Refer to Note 9 for more information. 16. DIVIDENDS AND DISTRIBUTIONS The following table summarizes the Company’s dividends declared during the years ended December 31, 2024 and 2023: Declaration Date Record Date Payment Date Per Common Share Distribution Amount Taxable Ordinary Income Qualified Dividends Return of Capital Section 199A Dividends 3/2/2023 3/31/2023 4/14/2023 $ 0.56 $ 0.55 $ 0.01 $ — $ 0.55 6/15/2023 6/30/2023 7/14/2023 0.48 0.48 — — 0.48 9/15/2023 9/30/2023 10/13/2023 0.48 0.36 0.12 — 0.36 12/15/2023 12/31/2023 1/12/2024 0.48 0.46 0.02 — 0.46 2023 Total cash dividend $ 2.00 $ 1.85 $ 0.15 $ — $ 1.85 3/4/2024 3/31/2024 4/15/2024 $ 0.48 $ 0.48 $ 0.07 $ — $ 0.41 6/13/2024 6/24/2024 7/15/2024 0.48 0.28 0.04 0.20 0.24 6/27/2024 7/8/2024 7/15/2024 0.15 0.05 0.01 0.10 0.04 9/13/2024 9/30/2024 10/15/2024 0.33 0.11 0.02 0.22 0.09 12/13/2024 12/31/2024 1/15/2025 0.33 (1) — — — — 2024 Total cash dividend $ 1.77 $ 0.92 $ 0.14 $ 0.52 $ 0.78 (1) The fourth quarter 2024 dividend paid on January 15, 2025 to shareholders of record as of December 31, 2024 will be taxable to shareholders in 2025. Holders of AFC Common Stock as of the close of business on July 8, 2024 (the “Record Date”) received one share of SUNS common stock for every three shares of AFC Common Stock held. For U.S. federal income tax purposes, AFC reported the fair market value of the SUNS common stock distributed per each share of AFC common stock outstanding on the Record Date was $ 11.00 per share. 17. DISCONTINUED OPERATIONS On July 9, 2024, the Company announced the completion of the previously announced separation and Spin-Off of the Company’s CRE portfolio into an independent, publicly-traded REIT, SUNS. The Spin-Off was effected by the distribution of all of the outstanding shares of SUNS common stock to the Company’s shareholders of record as of the close of business on July 8, 2024 (the “Record Date”). The Company’s shareholders of record as of the Record Date received one share of SUNS common stock for every three shares of the Company’s common stock held as of the Record Date. The Spin-Off was completed July 9, 2024 (the “Distribution Date”). On the Distribution Date, SUNS became an F-35 Table of Contents independent, publicly-traded company, trading on the Nasdaq Capital Market under the symbol “SUNS”. The Company retained no ownership interest in SUNS following the Spin-Off. On the Distribution Date, the Company recognized a reduction to additional paid-in capital of approximately $ 114.8 million in connection with the Spin-Off related to the transfer of certain assets and liabilities associated with its CRE portfolio to SUNS. In connection with the Spin-Off, the Company entered into several agreements with SUNS that govern the relationship between the Company and SUNS following the spin-off, including the Separation and Distribution Agreement and the Tax Matters Agreement. These agreements provide for the allocation between the Company and SUNS of the assets, liabilities and obligations (including, among others, investments, property and tax-related assets and liabilities) of the Company and its subsidiaries attributable to periods prior to, at and after the Spin-Off. The operating results of the SUNS business through the date of the Spin-Off are reported in net income from discontinued operations, net of tax in the consolidated statements of operations for all periods presented. The related assets and liabilities are reported as assets and liabilities of discontinued operations on the consolidated balance sheets. Cash flows from the Company’s discontinued operations are presented as such in the consolidated statements of cash flows for all periods presented. The following table summarizes the financial statement lines included in net income from discontinued operations, net of tax for the years ended December 31, 2024 and 2023: Years ended December 31, 2024 2023 Interest income $ 4,156,335 $ 244,742 Expenses General and administrative expenses ( 21,651 ) ( 120 ) Professional fees ( 1,140,762 ) ( 10,000 ) (Provision for) reversal of current expected credit losses ( 71,854 ) — Net income from discontinued operations, net of tax $ 2,922,068 $ 234,622 During the year ended December 31, 2024, Spin-Off costs incurred were approximately $( 0.5 ) million. No Spin-Off costs were incurred during the year ended December 31, 2023. Prior to the completion of the Spin-Off in the third quarter of 2024, Spin-Off costs were historically presented within professional fees in the consolidated statements of operations and are now included in the measurement and presentation of discontinued operations for all periods presented. There were no assets or liabilities classified as discontinued operations as of December 31, 2024. The following table summarizes the financial statement lines of assets and liabilities classified as discontinued operations as of December 31, 2023: As of December 31, 2023 Cash and cash equivalents $ 31,244,622 Total assets of discontinued operations $ 31,244,622 Accounts payable and other liabilities $ 10,000 Total liabilities of discontinued operations $ 10,000 18. REPORTABLE SEGMENTS ASC 280, Segment Reporting, establishes standards for reporting financial and descriptive information about an enterprise’s reportable segments. The Company generates revenue from loans to state law compliant cannabis operators in the United States. These investments typically have maturities ranging from two to five years and may accrue interest at F-36 Table of Contents either fixed or floating rates. The accounting policies of the institutional lending segment are the same as those described in the summary of significant accounting policies. The presentation of financial results as one reportable segment is consistent with the way the Company operates its business and is consistent with the manner in which the Company’s Chief Operating Decision Maker (“CODM”), the Company’s Chief Executive Officer, evaluates performance and makes resource and operating decisions for the business. The Company has no operations outside of the United States. The Company’s portfolio exhibits similar economic characteristics, similar yields and is operated using consistent business strategies. The Company operates as one operating segment and has one reportable operating segment for activities related to institutional lending. The CODM assesses performance and evaluates the allocation of resources of the Company on a consolidated basis, based on the Company’s net income from continuing operations, which is reported on the Company’s consolidated statements of operations. The CODM is regularly provided with only the consolidated expenses, as noted on the consolidated statements of operations. Significant segment expenses are listed on the accompanying consolidated statements of operations. The measure of segment assets is reported on the consolidated balance sheets as total assets. The CODM uses net income to evaluate income generated from segment assets and in deciding the amount of dividends to be distributed, as well as using net income as a basis for evaluating lender terms for loans with state law compliant operators. During the year ended December 31, 2024 and 2023, interest income earned on the Company’s portfolio was concentrated with three and four borrowers, respectively, each comprising more than 10% of consolidated interest income for an aggregate amount of $ 22.7 million, or 44 %, and $ 45.7 million, or 65 %, of consolidated interest income, respectively. 19. SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date the consolidated financial statements were available to be issued. There were no material subsequent events, other than those described below, that required disclosure in these consolidated financial statements. In January 2025, AFC Agent placed Private Company K in a consensual receivership to operate the collateral assets for the benefit of the Company, as a secured lender, and all other stakeholders. In February 2025, the Company entered into a $ 15.0 million senior secured credit facility with Private Company U, which was fully funded at closing. The loan was originated at a discount of 2.50 % and matures March 1, 2028. The loan bears interest at 14.00 %. In February 2025, AFC Agent, on behalf of the Company and the other lenders, initiated a mortgage foreclosure proceeding in connection with the 2024 Subsidiary of Private Company G Forbearance Agreement over a cultivation facility owned by Subsidiary of Private Company G. The Company also delivered a reservation of rights letter to Subsidiary of Private Company G concerning the occurrence of events of default and forbearance defaults under the credit agreement and the 2024 Subsidiary of Private Company G Forbearance Agreement, respectively, including unpermitted payments, the failure to maintain and preserve one of Subsidiary of Private Company G’s cannabis licenses and its cultivation facility and its failure to cooperate with the Company in the foreclosure proceeding. The Company believes these defaults have had a material adverse impact on Subsidiary of Private Company G’s ability to operate its business and make payments under the credit agreement. AFC Agent is also therefore pursuing a payment guarantee from the parent company and the beneficial shareholders of Subsidiary of Private Company G that guaranteed the loan. For more information on related risks, s ee “ Risk Factors—Risks Related to Our Business and Growth Strategy— Loans to relatively new and/or small companies and companies operating in the cannabis industry generally involve significant risks .” F-37 Table of Contents SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: March 13, 2025 ADVANCED FLOWER CAPITAL INC. By: /s/ Daniel Neville Daniel Neville Chief Executive Officer (Principal Executive Officer) Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. Date: March 13, 2025 ADVANCED FLOWER CAPITAL INC. By: /s/ Daniel Neville Daniel Neville Chief Executive Officer (Principal Executive Officer) By: /s/ Brandon Hetzel Brandon Hetzel Chief Financial Officer and Treasurer (Principal Financial Officer and Principal Accounting Officer) By: /s/ Alexander Frank Alexander Frank Director By: /s/ Thomas Harrison Thomas Harrison Director By: /s/ Robert Levy Robert Levy Director By: /s/ Marnie Sudnow Marnie Sudnow Director By: /s/ Leonard M. Tannenbaum Leonard M. Tannenbaum Chairman 111